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ABSTRACT 
 
Q fever is an infective, contagious and zoonotic disease caused by Coxiella burnetii, an 
obligate intracellular bacterium. The infection in ruminants is frequently subclinical, but 
late abortions, stillbirths and reproductive disorders can occur as well. Shedding of C. 
burnetii into the environment mainly occurs during parturition or abortion, but the 
bacterium is shed also in feces, urine, milk, vaginal mucus. 
The first goal of this research was to assess the efficacy of a diagnostic strategy based on 
real-time PCR (r-t PCR) assays on bulk tank milk (BTM) for the detection of infected 
dairy herds/flocks, with the aim of estimating the prevalence of Q fever infection in dairy 
herds and in goats flocks. The second goal was to evaluate the dynamics of the antibodies 
response and the C. burnetii excretion in infected animals. 
The sensitivity and specificity of a single r-t PCR test on BTM were evaluated using a 
control-case study in dairy herds and goat flocks. The first step was the identification of 
infected and negative farms, in which a sample of BTM was taken for a r-t PCR test to 
detect C. burnetii DNA. 
In dairy cattle the infected herds were defined as farms with: 
 clinical symptoms of Q fever like abortions or infertility and positive r-t PCR results 
confirming the presence of C. burnetii on specimens from affected animals or 
abortions, 
 a prevalence at least of 20%. 
Negatives farms were defined as farms with the following characteristics: 
 a regular surveillance and diagnosis of abortions, 
 all the r-t PCR test of the previous 2 years negative for C. burnetii, 
 a seroprevalence below 20%. 
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The same features were used for dairy goat flocks but the seroprevalence was set out at 
15%. 
C burnetii was detected in fetuses or placenta of 17 dairy cattle farms: among these herds 
only 8 were positive at the BTM r-t PCR (50%). Out of 22 negatives herds, sampled for 
prevalence assessment, 10 showed a prevalence < 20% and 12 ≥ 20%. All herds defined as 
uninfected had a r-t PCR negative in BTM sample. The sensitivity and specificity of BTM 
r-t PCR were respectively equal to 0.5 and 1. 
Out of the 29 flocks sampled in the study, 15 had goats shedding C. burnetii from vaginal 
mucus after abortions and also after normal parturition. No abortion storms were detected 
during the study, but only single cases of abortion. In the flocks where C. burnetii was 
detected, the prevalence was ≥ 15% in 9 farms. Among these flocks, 7 out of 9 had a 
positive r-t PCR BTM sample.  
In the 14 flocks with C. burnetii negative vaginal swabs or abortions, none had a 
prevalence < 15% and a negative r-t PCR in BTM sample. The sensitivity and specificity 
of BTM r-t PCR was respectively equal to 0.8 and 1. The difference between cattle and 
goats sensitivity is probably due to the different features of the reproduction cycle. In goats 
kidding are seasonal and C. burnetii is shed in milk more often in the two months 
following kidding, that was exactly the time of BTM sampling in this study, while in cattle 
calving they are widespread all over the year.  
To study the C. burnetii transmission in dairy herds, a longitudinal study was designed as 
follow: 
1. 4 dairy herds were selected, among the infected farms, 
2. a sample of blood and milk was taken from every lactating cow and tested, serum 
with ELISA and CFT for antibodies detection, milk r-t PCR for C. burnetii DNA 
detection, 
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3. according to test results, 4 groups of nearly 10 cows were established to be sampled 
3 times every 2 months. The cows were sorted among the groups as follows: 
 group 1: cows ELISA negative and PCR negative (ELISA-PCR-), 
 group 2: cows ELISA negative and PCR positive (ELISA-PCR+), 
 group 3: cows ELISA positive and PCR negative (ELISA+PCR-), 
 group 4: cows ELISA positive and PCR positive (ELISA+PCR+). 
4. From these cows at each sampling a sample of blood, milk and feces was taken and 
tested: serum with ELISA and CFT for antibodies detection, milk and feces with r-t 
PCR for C. burnetii DNA detection. 
The same study was performed in 3 goat flocks, all infected by C. burnetii. The goats were 
sorted among 3 groups and lacked the group ELISA-PCR+ because was found only 1 goat 
ELISA-PCR+. 
The results highlighted in dairy cows a great gap between the seroprevalence and the 
percentage of shedders found in the herds. The seroprevalence was on average 30,6%, 
while the percentage of shedders was at least 13% and the percentage of strong shedders 
was only 1,7%. We observed also the presence of 14 cows shedding C. burnetii in milk 
without an appreciable serological response: of these cattle 11 remained seronegative up to 
six months. The time of shedding in these cows was very short: after 2 months 12 cows 
were PCR negatives and from the 3rd sampling all cows remained negatives to PCR. 
Many ELISA+PCR- cows were found shedding C. burnetii in milk in the following 
samplings. The ELISA+PCR+ cows behaved oppositely : these cattle gradually, during the 
study, became PCR-, but remained seropositive until the end. 
Shedding in feces was sporadic and only 9 cows were found to shed the bacterium 
occasionally through this route. 
In dairy herds we evaluated also the association between the serological response of the 
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cow to ELISA or CFT test and the occurrence of C. burnetii shedding in milk. The results 
obtained highlighted a high statistically significant association (p value = 0.00) of both 
ELISA and CFT, especially for the detection of persistent shedders with an odd ratio (OR) 
equal to 6.8 for CFT and 29.4 for ELISA. By increasing the ELISA cut-off to a value s/p > 
2, only cows with a high serological titer were detected and these animals had a greater 
probability of being persistent shedders. Using this criteria for detection of seropositive 
cows, a highly significant association (OR = 18.4; p value = 0.00) was found between 
serological results and r-t PCR in milk.  
The goats sampled were 257, coming from 3 flocks very different in size, ranging from 12 
to 171 goats. The shedders of C. burnetii in milk were 59 (23%), the ELISA seropositive 
goats 177 (69%), the CFT seropositive goats 11 (4%). The percentage of shedders in milk 
was very different among the flocks, ranging from 100% of farm 2 to 1% of farm 3. At 2nd 
sampling in flocks 1 and 2 the numbers of shedders declined sharply, while in flock 3 the 2 
shedders founded carried on the excretion until respectively 3rd and 4th sampling. Shedding 
of C. burnetii in stools was detected only occasionally in flocks 2 and 3, while in flock 1 at 
2nd sampling 15 positives goats were detected, at the 3rd 13, and at 4th 5. The great majority 
of ELISA seropositive goats kept this status throughout the study time: only 3 goats out of 
38, tested negative for antibodies at 3rd sampling. Among seronegative goats only 3 
animals showed seroconversion during the study. The serological response to CFT showed 
remarkable variations at each sampling: first the percentage of positive goats was low or 
even 0, in the following samplings the percentage rose to 35% and even to 90% in one 
flock, then all the goats returned negative. 
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INTRODUCTION 
 
Q fever is an infective and contagious disease caused by Coxiella burnetii, an obligate 
intracellular bacterium. It’s a zoonotic disease widespread all over the world except for 
New Zealand and is considered as emerging or re-emerging in many countries. This 
bacterium can infect a wide range of species, susceptible hosts including farm animals, 
pets, wild mammals and even non-mammalian such as domestic and wild birds, reptiles 
and ticks (Raoult et al., 2005). 
The most common reservoir of the infection are domestic ruminants and humans are 
primarily infected by inhaling aerosols contaminated with the bacteria (ECDC, 2012). In 
domestic ruminants, which represent the major source of human infections, the disease is 
frequently subclinical, but late abortions, stillbirths and reproductive disorders can occur as 
well (Arricau-Bouvery and Rodolakis, 2005). Shedding of C. burnetii into the environment 
mainly occurs during delivery or abortion, but the bacterium is shed also in feces, urine, 
milk, vaginal mucus (Angelakis E., Raoult D., 2010). 
In cattle, as in small ruminants, in addition to the peripartum excretion other periods of 
shedding can be observed: infected cows can persistently shed bacteria in milk for months 
without symptoms, while sporadic or intermittent shedding can occur in feces or vaginal 
mucus (Guatteo et al., 2007).  
Factors affecting the maintenance of C. burnetii infection in animal populations can be 
grouped according to: 
a) Agent factors, related to the characteristics of C. burnetii, and in particular infectivity, 
virulence and resistance to environmental conditions; 
b) Host factors, including animal species, susceptibility, infectiousness, age and sex;  
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c) Environment factors , related to animal management, as well as manure management 
and farm characteristics. 
Diagnosis, particularly the determination of the shedder status, is a critical and expensive 
process that is not yet completely standardized. Several methods are available for diagnosis 
of C. burnetii infection in animals, including both direct identification of the agent and 
serological testing. Isolation of C. burnetii can be done by cell or embryonated chicken egg 
culture. Such methods are complex and require level 3 containment (OIE) so they are not 
usually adopted in routine diagnostics laboratories (EFSA, 2010). Polymerase chain 
reaction (PCR) is one of the most analytically sensitive and rapid method for both the 
direct detection of C. burnetii and the identification of shedders, and the ability to detect 
and quantify C. burnetii DNA by real-time PCR has dramatically enhanced diagnostic and 
research approaches. Real-time PCR can be used on a wide range of samples: vaginal 
discharge, abortion material, feces and milk, bulk or individual (Kim et al., 2005). 
However, also with real-time PCR the detection of shedders is still complex because the 
shedding dynamics are not well known (Guatteo et al., 2007; Sidi-Boumedine et al., 
2009;). 
For the serological diagnosis of Q fever there is no officially (OIE) prescribed test, but 
among the various techniques that can be employed, the 3 most often used are the indirect 
immunofluorescence assay (IFA), enzyme linked immunoassay test, (ELISA) and the 
complement fixation test (CFT). Serological assays are suitable for the screening of herds 
or flocks, but interpretation at the individual animal level is not possible. The CFT was 
considered the reference test for historical reasons but its diagnostic sensitivity was highly 
variable . The analytical sensitivity of the ELISA was found to be 8-16 times higher than 
that of the best CFTs (EFSA, 2010). At present, ELISA is the recommended choice for 
seroprevalences studies (Natale et al., 2012).  
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During the last decade our knowledge on Q fever has increased, however  the persistent 
considerable uncertainty about this infection calls for more research. Recently the 
European food safety authority (EFSA) scientific opinion on Q fever (2010) pointed out 
several items to be clarified by new investigations, concerning diagnostic methods, factors 
influencing the maintenance of infection and characteristics of the bacterium, like host 
specificity and virulence factors. 
Several methods are available for diagnosis of C. burnetii infection in animals, including 
both direct identification of the agent and serological testing, but none of these is an 
officially designated test. The diagnosis of the infection should involve the use of multiple 
techniques and can be effectively  interpreted only at herd or flock level.  
The first goal of this research was to assess the efficacy of a diagnostic strategy based on 
real-time PCR assays on bulk tank milk (BTM) for the detection of infected dairy 
herds/flocks, with the aim of estimating the prevalence of Q fever infection in dairy herds 
and in goats flocks. The second goal was to evaluate in infected animals the dynamics of 
the antibodies response and the C. burnetii excretion. 
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CHAPTER 1: Coxiella burnetii in animals and humans 
 
1.1 HISTORICAL BACKGROUND 
 
Q fever was described in 1935 as an outbreak of febrile illness in slaughterhouse workers 
in Brisbane, Australia (Derrick EH, 1973). Derrick examined all those who were affected 
and could not produce a diagnosis, as a result, he named the illness ‘‘Q’’ for query fever. 
Later, some workers suggested that the Q stood for Queensland, the state in which the 
disease was first described. 
Burnet and Freeman (1937) reproduced the disease in guinea pigs and  mice with an 
emulsion of infectious guinea pig liver received from Derrick and demonstrated Rickettsial 
organisms in spleen sections from infected mice (Burnet and Freeman 1983). 
In the same period, Davis and Cox (1938),working on the possible vectors of Rocky 
Mountain spotted fever at the Rocky Mountain Laboratory in Hamilton,Montana, USA, 
allowed Dermacentor andersoni ticks collected near Nine Mile Creek, Montana, to feed on 
guinea pigs and found that some animals developed a febrile illness with enlarged spleens. 
They further characterized the “Nine Mile” agent. The organism was observed 
intravacuolarly in infected tissue cultures and was found to cause an infection in people 
(Cox et al., 1947). 
Both groups in Brisbane and Montana demonstrated that the etiological agent displayed 
properties of both viruses and Rickettsiae in 1938, Rickettsia diaporica, the proposed name 
for the organism, which incorporated both Rickettsial features and the ability of the 
organism to pass through a bacteriological filter, was propagated in tissue cultures and in 
developing chicken embryos (Cox, 1941).  
American and Australian groups started exchanging information and infected materials 
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after a laboratory-acquired Q fever infection occurred in the Rocky Mountain Laboratory 
in 1938 (Dyer, 1949). They demonstrated that the Australian Q fever agent, the zoonotic 
agent, and the Nine Mile agent were in fact isolates of the same microorganism, Rickettsia 
burnetii (Maurin and Raoult, 1999), later renamed as Coxiella burnetii (Philip, 1952), a 
name which honours both Cox and Burnet as pioneers in this field. 
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1.2 ETIOLOGY 
 
1.2.1 Bacteriology 
C. burnetii is a small pleomorphic rod (0.2–0.4 mm wide, 0.4–1.0mm long) obligate 
intracellular bacterium, with a membrane similar to that of a Gram-negative bacterium 
(Maurin and Raoult, 1999). Historically the bacterium was classified in the order of 
Ricketsiales, but now, based on 16S rRNA sequence analysis, had been placed in the 
Coxiellaceae family in the order Legionellaes of the gamma subdivision of Proteobacteria 
(Raoult et al., 2005). 
C. burnetii replicates, with an estimated doubling time of 20–45 hours, within a 
parasitophorous vacuole of eukaryotic host cells (Mertens and Samuel, 2007). This 
microorganism has a intracellular development cycle that involves 3 distinct cells type: 
large cell variant (LCV), small-cell variant (SCV) or small dense cell (SDC) (Angelakis 
and Raoult, 2010).  
The 3 forms can be distinguished by morphologic, antigenic, metabolic differences, and 
physical and chemical resistance (Heinzen and Hackstadt, 1999). The LCV, which share 
features common with Gram-negative bacteria, have diffuse chromatin and possess clearly 
distinguishable outer and cytoplasmic membranes with exposed LPS on the surface. They 
are the metabolically active intracellular form of C. burnetii, and are larger, more 
pleomorphic and less electron dense than the other two forms (Arricau-Bouvery and 
Rodolakis, 2005). The LCV form undergoes sporogenic differentiation to produce 
resistant, spore-like forms, the SDC and SCV, that are able to survive extracellularly as 
infectious particles (Angelakis and Raoult, 2010). The SCV is a compact small rod with a 
center of condensed nucleoid filaments. The SDC resemble the SCV in morphology but are 
distinct from this form as a result of a higher physical stability (McCaul et. al., 1991), that 
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is highlighted from the resistance of these cells to a pressure treatment of 50,000 psi 
(corresponding to 350,000 KPa) (Samuel et al., 2003). The SDC have been visualized in 
LCV as endospores and may be liberated upon the lysis of LCV or binary transverse 
fission with unequal cell division (McCaul et. al., 1981).  
The formation of the different forms is linked to the lifecycle of C. burnetii, a strategy 
developed to survive in and out of the parasitophorous vacuole. The SCV and SDC forms 
enter into the eukaryotic cells by microfilament dependent endocytosis and after the 
acidification of the phagosome (about pH 5.5) the SCV and SDC cells multiply by 
transverse binary fission and differentiate to LCV (Arricau-Bouvery and Rodolakis, 2005). 
The fusion of the phagosome with the lysosome leads to the formation of the 
phagolysosom, and to a further acidification (about pH 4.5) that is an absolute requirement 
for the replication of the LCV cells. At this pH, an exponential growth of the LCV cells 
occurs for 4-6 days, then a stationary phase starts and coincides with the reappearance of 
SCV cells (Rodolakis, 2011).  
These 3 bacterial forms express different proteins, specific for each form, in the 
developmental life cycle (Heinzen and Hackstadt, 1996; Heinzen et al., 1999; Seshadri et. 
al, 1999) and recognized by antibodies produced during a C. burnetii infection. These 
differentially expressed antigens could allow the bacteria to escape the immune response. 
In particular the major outer protein P1, which functions as porin, is absent in SDC cells 
and (McCaul et al., 1991) and is responsible for the great resistance of C. burnetii in the 
environment. 
C. burnetii displays antigenic variation similar to the smooth–rough variation of other 
Gram-negative bacteria and this variation is related to changes in the lipopolysaccharides 
(LPS) layer (Woldehiwet, 2004). After several passages in embryonated eggs or cell 
culture, the bacterial population shifts from a virulent (phase I) to an avirulent phase (phase 
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II), which corresponds to the rough variants of other Gram negative bacteria. C. burnetii 
phase I bacteria expresses a smooth full-length LPS and are highly infective and naturally 
found in infected animals, humans and ticks, while phase II bacteria are avirulent and 
characterized by a truncated LPS that lacks completely the O-antigenic polysaccharide 
chain (Mertens and Samuel, 2007), and also some protein cell surface determinants 
(Amano and Williams, 1984). Early activation of immune cells depends primarily on LPS, 
and the full-length LPS of phase I bacteria seems to have a masking effect protecting the 
bacteria from Toll-like receptors type 2 (TLR2) recognition (Mertens and Samuel, 2007). 
 
1.2.2 Genomic 
Strains of C. burnetii have been shown to belong to six (I–VI) genomic groups on the basis 
of restriction fragment length polymorphism (RFLP) (Hendrix et al., 1991). It remains to 
be clarified whether the phase variation of C. burnetii is related to genetic variation 
(Maurin and Raoult, 1999) similar to that observed in Pseudomonas aeruginosa (Zielinski 
et al., 1991). 
C. burnetii possesses a small circular chromosome of approximately 2 Mbp (Mertens and 
Samuel, 2007). Most isolates harbor additionally one out of four plasmids of 32 to 51 kb in 
size, defined as: QpH1, QpRS, QpDG, QpDV (Jäger, 1998). Strains without a resident 
plasmid carry instead a 16 kb plasmid-like sequence integrated in the chromosome 
(Mertens and Samuel, 2007). The plasmids seem to be of major importance for virulence 
because their common sequences are conserved among all isolates of C. burnetii, but their 
biological significance is still unclear (Arricau-Bouvery and Rodolakis, 2005).  
The genome is predicted to encode 2,134 coding sequences larger than 30 aa, of which 719 
(33.7%) are hypothetical with no significant similarity to other genes in the database 
(Arricau-Bouvery and Rodolakis, 2005). In the genome of C. burnetii 83 pseudogenes 
have been identified: many of these genes contains single frameshifts, points mutations, 
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truncations, which suggest that the genome reduction is a relatively early, and still ongoing 
process. Unlike other intracellular bacteria, C. burnetii genome has a great variety of 
mobile elements: in particular 29 insertion sequence (IS) elements are present. There are 
21 copies of a unique IS110-related isotype, named IS1111, 5 IS30 and 3 ISAs1 family 
elements, and 3 degenerate transposase genes of unknown lineage (Hoover et al., 1992). 
The IS1111 sequence analysis highlighted a less than 2% divergence among the strains 
tested (Mertens and Samuel, 2007).  
Several attempts were made to discriminate among the different C. burnetii strains based 
on phenotypic and genomic characteristics, especially for the individuation of specific 
pathological features. Initially, the plasmid profile was associated with the so-called acute 
or chronic C. burnetii isolates, originating respectively from acute or chronic Q fever 
patients. However, recent findings by PCR analysis of C. burnetii strains from patients 
exhibiting chronic Q fever have revealed that there is no correlation between the plasmid 
type and the acute or chronic human infection (Arricau-Bouvery and Rodolakis, 2005). 
Restriction fragment length polymorphism (RFLP) analysis of genomic DNA demonstrates 
a considerable heterogenic banding pattern for the classification of genomic groups 
(Mertens and Samuel, 2007). Six distinct genomic groups were identified that can be 
correlated with specific plasmid types and clinical symptoms (Hendrix, 1991). Multispacer 
sequence typing (MST) was performed on 173 isolates to characterize different isolates of 
C. burnetii at the molecular level (Glazunova et al., 2005). This method is based on the 
comparison of the nucleotide sequences of internal regions between different genes, 
because they are considered highly variable since they are subject to lower selection 
pressure than the adjacent genes (Mertens and Samuel, 2007). Three monophyletic groups 
were identified based on MST: a correlation between the geographical distribution and the 
sequence type was found. Moreover this study demonstrated a correlation between 
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plasmide type and the disease outcome (acute or chronic infection) and an association 
between some genotypes and disease type (Glazunova et al., 2005).  
Recently, researchers from different countries have applied the multiple loci variable 
number of tandem repeat analysis (MLVA) method to C. burnetii strains typing because of 
its quite high discriminatory power and its applicability either to isolated bacterial strains 
or directly to DNA extracted from clinical samples (Arricau-Bouvery et al., 2006; Svraka 
et al., 2006). French researchers identified within the C. burnetii genome a total of 17 
different minisatellite and microsatellite markers to be used in MLVA genotyping in 2 
successive panels (Arricau-Bouvery, 2006). A third panel was implemented during the 
Dutch Coxiella burnetii outbreak, involving 6 microsatellite markers (Klaassen et al., 2009; 
Tilburg et al., 2012). 
 
1.2.3 Resistance features 
C. burnetii is able to survive in the outdoor environment for long time and persist in 
contaminated food, due to its physical characteristics that include stability against acids (up 
to pH 4.5), temperature (62° C for 30 minutes), UV light and pressure (up to 300.000 kPa) 
(EFSA, 2010). C. burnetii can survive for up to 42 months at 4-6°C in milk, 12 to 16 
months in wool, 120 days in dust, 49 days in dried urine, 30 days in dried sputum (EFSA, 
2010). Further, the organism can survive for more than 6 months in 10% saline (Williams 
1991). C. burnetii is killed following exposure to 5% chloroform or formaldehyde gas (in 
an 80% humidified environment) with less than 30 minutes exposure, to 5% H2O2, 0.5% 
hypochlorite and 70% ethanol (all with 30 minute exposure), and following pasteurization 
(at least 72°C for 40 seconds) (Angelakis and Raoult, 2010; EFSA 2010). 
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1.3 EPIDEMIOLOGY 
 
1.3.1 Transmission 
C. burnetii is characterized by a remarkable resistance to adverse environmental 
conditions. The organism is readily excreted in milk, urine, feces and uterine discharge of 
affected cattle, sheep, goats and other ungulates (Rodolakis, 2009). C. burnetii is present in 
very high numbers in the amniotic fluid, the placenta and foetal membranes of parturient 
ewes, goats, cattle and infected aerosols are generated from desiccation of infected 
placenta, body fluids, manure or contaminated dust (Arricau-Bovery and Rodolakis, 2005). 
Animals may continue to shed infectious particles for time long after abortion (Berri et al., 
2001). Parturition and abortions in animals associated with specific climatic conditions, 
especially dry, windy weather, has been reported as the main risk factors associated with 
spillover of infection from domestic ruminants to humans in different European Union 
(EU) members state (EFSA, 2010). Infection of domestic ruminants is usually seasonal and 
it occurs mainly in relation to lambing or calving seasons. In sheep, some experimental 
evidence suggests that pregnant animals are more susceptible to infection than non-
pregnant ones (Woldehiwet, 2004). 
C. burnetii is unique among the members of the family Rickettsiaceae in its non-
dependence on arthropod transmission, but ticks and other arthropods may be a source of 
infection for domestic animals. Marrie (1988) hypothesized that there may be an 
epidemiological circuit involving ticks, wild rodents, cats and man. Infected ticks are 
important for the maintenance of the whole cycle of the organism in nature but not 
essential vectors for animal or human infection (Woldehiwet, 2004; Marrie, 2007). 
The factors affecting the maintenance of C. burnetii infection in animal populations can be 
grouped according to: 
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a) agent, relating to the characteristics of C. burnetii, and in particular infectivity, virulence 
and resistance to environmental conditions; 
b) host, including animal species, susceptibility, infectiousness, age and sex; 
c) environment, related to animal management, as well as manure management and farm 
characteristics. 
Agent factors 
The importance of strain as a risk factor for both maintenance of infection and disease 
progression is unknown. The relationship between genotype/isolates and virulence is at the 
moment unclear, but the presence of a more virulent strain or a genetic shift to a more 
virulent strain has been suggested as an important factor in the occurrence of the outbreaks 
(Roest, 2011). Using MLVA Roest and others found that, in the outbreaks occurred in The 
Netherland during 2007-2010, 1 genotype of C. burnetii predominated on all dairy goat 
farms. This finding strongly suggests a clonal spread of C. burnetii with this predominant 
genotype over the dairy goat farms in the southeastern part of the Netherlands. The clonal 
spread of this single genotype could have been facilitated by the emergence of a genotype 
of C. burnetii causing abortion in dairy goats, that could then spread successfully over the 
dense goat population in the southeastern part of the country (Roest et al., 2012).  
C. burnetii is highly resistant to environmental conditions, surviving for many months 
under a range of conditions (EFSA, 2010; Rodolakis 2011). This feature can explain the 
ubiquitous nature of C. burnetii and the occurrence of outbreaks in humans far away from 
their animal source as happened in the Marseille area and in a town in the French Alps 
(Marrie, 2007). In the first outbreak the presence of contaminated waste from sheep and of 
strong wind were the key factors for the widespread of infection, while in the second 
outbreak the presence of a helicopter landing area near  a slaughterhouse created winds that 
facilitated the airborne spread of C. burnetii (Marrie, 2007). 
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Host factors 
Host factors play a key role in the natural history of C. burnetii infection in human and 
animals. Animal proximity and contact with infected animals and/or their contaminated 
products (e.g. birth products) have been identified as important risk factors for humans. In 
most outbreaks, there are reports of spill-over of infection to humans from infected 
domestic small ruminants like goats or sheep. In contrast, there is no evidence of any major 
contribution of cattle in the history of Q fever in humans (Georgiev et al., 2013). Further, 
the evolution of disease, including clinical signs, is not the same in cattle, as in sheep or 
goats. The duration of excretion of the agent, husbandry conditions and other factors may 
each play an important role in the differences observed in animal seroprevalence and the 
persistence of infection. C. burnetii excretion can last up to several months in ruminants, 
with some differences among the species. The longest duration of excretion found during 
the follow up of naturally or experimentally infected animals were: 
 14 days in feces, 13 months in milk in cows, 
 14 days in vaginal mucus, 20 days in feces, 52 days in milk in goats, 
 71 days in vaginal mucus, 8 days after lambing in feces, 8 days in milk in sheep 
(Arricau-Bouvery and Rodolakis, 2005). 
Environment factors 
A range of environmental factors have been suggested to influence the maintenance of 
infection in farmed animal population, including increased herd/flock size, animal density, 
and herd/flock density (EFSA, 2010). Pathogen pressure is likely to increase in association 
with farm factors that increase the concentration of C. burnetii in the environment. 
C. burnetii contaminated manure has been identified as a source for Q fever in human 
outbreaks ((Arricau-Bouvery and Rodolakis, 2005; EFSA, 2010; Roest et al, 2011a). It is 
likely that it also plays a role on the maintenance of infection in livestock. 
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1.3.2.Host distribution 
Q fever is a zoonosis affecting a wide range of hosts. Horses, pigs, dogs, cats, camels, 
buffaloes and also wild and domestic birds such as chickens, pigeons, ducks, geese and 
turkeys can be infected without showing any clinical signs. C. burnetii has also been 
isolated from rabbits, cats squirrels, mice, deer and other free-living animals (Woldehiwet, 
2004). Farm animals such as cattle, sheep and goats are the most important reservoirs for 
human infections (Rodolakis, 2006; Marrie, 2007). Evidence of infection has also been 
shown in various species of ticks, fleas, mites, flies and other arthropods (Dyer, 1949; 
Babudieri and Moscovici, 1952). Over 40 tick species can be naturally infected with C. 
burnetii: the organism multiplies in the gut cells of ticks and large numbers of C. burnetii 
are shed in tick feces. Nevertheless infected ticks seems not to be important in the 
maintenance of infections in livestock or humans, they are probably most important in 
maintaining the whole cycle of Coxiella burnetii (Marrie, 2007). 
C. burnetii infection is widespread all over the word with the exception of New Zealand, 
occurring in diverse geographic regions and climatic zones (Hilbink et al., 1993; 
Woldehiwet, 2004 ). The real incidence of the infection both in humans and animals is 
underestimated in several countries due to the preponderance of asymptomatic cases and 
the lack of efficient diagnostic tools (Porter 2001; EFSA, 2010). In Africa studies on the 
seroprevalence of the infection have been carried out mainly in Egypt, Sudan, Morocco, 
Tunisia, Chad, South Africa, and in all the states of the Western part of the continent. A 
seroprevalence ranging from 4% up to 55% was found in cattle, while in small ruminants 
the seroprevalence ranged from 13% to 33%. In camels a study carried out in Chad found a 
seroprevalence of 80% (Vanderburg et al., 2014). 
In the United States of America (USA) the prevalence of the disease in dairy cattle was 
estimated greater than 90% analyzing bulk tank milk in one study (Kim et al., 2005), and 
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in a recent study involving both dairy and goats herds the presence of C. burnetii DNA was 
found in the 96% of the farms tested (Pearson et al., 2014). Several seroprevalence studies 
have been performed in USA to assess the diffusion of C. burnetii in animals. The greater 
prevalence was found in goats (41.6%) and in sheep (16.5%): in dairy cattle, despite the 
widespread of the etiological agent in dairy farms, the seroprevalence founded was lower 
than 5% (McQuiston and Childs, 2002).  
In Humans the 3.1 % of the population was found seropositive (Anderson et al., 2009) but 
among veterinarians a seroprevalence almost equal to 22% was found in a different study 
(Whitney et al., 2009).  
In Europe C. burnetii infection is prevalent in domestic ruminants (cattle, sheep, and goats) 
in a wide range of countries, based on the results of serological testing over the last 
decades, listed in table 1, 2 and 3 (EFSA, 2010). In recent studies herd prevalence for cattle 
was estimated to be up to 73.0%, in France, and up to 37.0 % in the Netherlands. For goats 
it was 40.0% in France and 17.8% in the Netherlands, while for sheep values of 89.0% in 
France, and 14.5% in the Netherlands were respectively found (Georgiev et al., 2013). 
Within-herd prevalence estimates for cattle were up to 20.8% in Bulgaria, 15.0% in 
France, 19.3% in Germany,, 21.0% in the Netherlands, for goats up to 40.0% in Bulgaria, 
88.1% in France, 2.5% in Germany, 7.8% in the Netherlands, and for sheep up to 56.9% in 
Bulgaria, 20.0% in France, 8.7% in Germany, 3.5% in the Netherlands (Georgiev et al., 
2013). 
In humans Q fever has been endemic in large parts of Europe for several decades. 
Estimates of prevalence of C. burnetii infection in human, based on serological studies 
conducted in France, The Netherlands, Bulgaria and Germany since 1982 to 2010, are 
listed in Table 4 (Georgiev et al., 2013). Seroprevalence studies from the period 1970–
2009 show that 10–30% of rural populations in different parts of Europe have antibodies 
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against C. burnetii. The seroprevalence is higher in farmers working with cattle or sheep, 
and highest in persons who are in contact with the products of animal births or abortions. 
Other high-risk groups for infection are veterinarians and personnel in research 
laboratories working with animals (Lahuerta et al., 2009; Frode Forland et al., 2010).  
There is significant variation in the levels of seroconversion throughout the EU, but that at 
the general population level, there are typically a small percentage of individuals (often 
between 2-10%) that have evidence of having been infected with C. burnetii. This 
evidence inevitably rises in areas with outbreaks of human Q fever, or where outbreaks are 
commonly reported and there is some endemicity of C. burnetii (Eurosurvilliance, 2010).  
In 2007, the broad epidemiological situation from reported data was that 22 EU and 
European Free Trade Association (EFTA) countries reported a total of 669 cases of Q fever 
(8 countries reported zero cases), 637 of which were confirmed. In 2008, 24 EU/EFTA 
countries reported 1,599 Q fever cases (1,594 confirmed), representing an increase of over 
170% from the previous year. This increase was mainly attributed to the increase in the 
Netherlands. The number of cases per year reported usually in the Netherlands from 1980 
to 2007 was on average 20 a year (van der Hoek et al., 2012). In 2007 a total of 168 human 
cases was notified in a specific area, the Noord-Brabant. Dairy goats were identified as the 
source of the human Q fever due to a considerable number of Q-fever abortions in goats: 
the unusually hot and dry weather in the spring 2007 seems to have caused airborne 
transmission of contaminated dust particles (van der Hoek et al., 2012). The number of Q 
fever cases increased dramatically in 2008 and it became evident that the 2007 outbreak 
was not an isolate incident. A total of 3,489 patients affected from Q fever were reported 
between 2007 and 2009 and looking at the epidemic curve of the disease (figure 1) during 
this time, a seasonal pattern could be observed with the most cases occurring in spring and 
early summer (van der Hoek et al., 2012). The exponential spread of Q fever stopped since 
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2010 and the notification of cases ended by 2011. Drastic veterinary intervention such as 
culling of pregnant goats from infected farms, massive use of vaccination and enforced 
hygiene measures were able to stop the widespread of the disease in humans and animals.  
A posteriori, it would be difficult to establish if this epidemic in The Netherlands, with 
3523 human cases within 3 consecutive years, represents a unique phenomenon (Roest et 
al., 2011). The epidemiological situation of Q fever infection in The Netherlands till the 
year 2006 was very similar to the most of European countries, with high seroprevalence in 
animal population but few human cases (EFSA, 2010).  
It is not clear why Q fever became a major problem in The Netherlands but not elsewhere. 
Several factors might have facilitated a change in epidemiology in goats : first, an increase 
in goat density in specific areas of The Netherlands and second, the extension of farms 
over the years. The increase in goat density took place in the highly populated province of 
Noord-Brabant. This proximity to a source excreting high numbers of C. burnetii during 
abortion, with transmission facilitated by dry weather and high numbers of susceptible 
humans is probably the main cause of the human Q fever outbreak in The Netherlands. 
These two factors associated with the new introduction of a more virulent strain or a 
genetic shift to a more virulent strain could have affected in-herd and between-herd 
dynamics of Q fever, resulting in the human and animals outbreaks (Roest et al., 2011). 
The Q fever outbreaks occurred in The Netherlands showed that this infection can easily be 
missed in the human field as well in the veterinary field and that good monitoring and 
surveillance systems are necessary to assess the real magnitude of Q fever.  
The most important lesson learned from the Dutch Q fever outbreak is that a close 
cooperation between the human and veterinary fields is essential for responding to 
outbreaks of zoonotic diseases. Specific disease knowledge and diagnostic tools from both 
fields are needed to manage outbreaks (Roest et al., 2014). 
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1.3.3 Q fever in Italy 
C. burnetii infection in ruminants has been reported in Italy since 1949 associated to 
human outbreaks occurred in Marche region in 1949-51 (Moretti 1984), Abruzzo in 1953 
(Caporale et al, 1953) and Sicily (Moretti 1984). The infection in ruminants is widespread 
in all the country as demonstrated by several studies performed in different area of Italy. In 
the Emilia Romagna region Martini et al. in 1994 found in dairy herds, using CFT, a 
prevalence rate of 13.1%. In the same region Cabassi et al. (2006) analyzing 650 sera from 
dairy cattle with abortion and 600 randomly-selected control sera found a seroprevalence 
equal to 44.9% in the animals which experienced abortion and equal to 22% in the control 
group. In the Veneto region both a seroprevalence of 18.2% in dairy cows after abortion 
was reported and the identification of C. burnetii in 2.8% of the cattle fetuses tested during 
the routine diagnostic activity from 2005 to 2008 (Barberio at al., 2009). In the same 
region a serological study performed on bulk tank milk in the province of Vicenza in 2010 
highlighted that among 489 herds tested, 290 (59%) were positives (Barberio et al., 2010). 
A survey performed in 2007-08 in the Lombardia region using a PCR method for the 
detection of C. burnetii DNA in bulk tank milk of 400 dairy cattle herds, showed that the 
40% of the milk samples analyzed were positive (Mannino et al., 2009). In South of Italy 
C. burnetii has been detected in the 11.6% of cattle aborted fetuses , and in the 21,5% of 
sheep and goats aborted fetuses (Parisi et al., 2006). In water Buffalo in the Campania 
region a survey performed in 2009 reported a prevalence of 17.5% fetuses positive for C. 
burnetii among 164 examined (Perugini et al., 2009).  
In spite of the spread of the infection in ruminants, few Q fever outbreaks in humans have 
occurred in Italy since the first report of the disease in American soldier in 1945 
(Commission on acute respiratory diseases, 1946) at the Grottaglie Air base (near Taranto 
in the Puglia region). 
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Others outbreaks were reported between 1946 and 1960 in Abruzzo (Caporale et al., 1953), 
Campania, Sardinia, Friuli Venezia Giulia (Simeoni, 2009): all these outbreaks were 
associated with the contact with parturient animals or with the passage of sheep flocks 
during lambing time. More recently, 4 outbreaks involving several people were reported. 
The first two occurred in 1987 and 1988 inside an agricultural community for the 
rehabilitation of drug users in San Patrignano (Rimini, Emilia Romagna). Approximately 
40% of the residents were human immunodeficiency virus (HIV) positive and 235 of them 
presented with clinical evidence of a flulike syndrome that was confirmed to be Q fever. 
The source of infection was correlated with activities in a sheep farm (Boschini et al., 
1999). 
The third one occurred in the area of Vicenza in Veneto in 1993 (Manfredi-Selvaggi et al., 
1996): a total of 58 human cases were identified in a 5 month period and 48% patients 
were hospitalized. Three flocks of sheep which passed through the outbreak area between 
late May and early June were shown to be infected, with prevalence of antibodies ranging 
between 45 and 53%. The case-control study showed a significant association with 
exposure to flocks of sheep (Odds ratio = 6.1). 
The last one occurred in winter 2003 in a prison population near the city of Como, in the 
Lombardia region. Overall, 65 of the 600 prison inmates developed the disease. The most 
probable source of infection has been identified in infected dust diffusion, helped by windy 
and dry weather, from sheep flock that passed through this area (Starnini et al., 2005). 
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1.4 PATHOGENESIS 
 
1.4.1 Pathofisiology 
In ruminants the most important route of infection from C. burnetii is the oral route and the 
portal of entry is the oropharynx. (McQuiston and Childs, 2002). On the contrary in 
humans the most important route of infection is inhalation of bacteria-contaminated dust, 
while the oral route is considered of secondary importance (Porter el al., 2011). Once 
inhaled or ingested, the extracellular form of C. burnetii (SCV or SDC) attaches itself to 
the cell membrane of monocytes/macrophages, the only known target cells and is 
internalized into the host cells by phagocytosis. Virulent C. burnetii organisms survive 
inside human monocytes, whereas avirulent bacteria are eliminated (Capo et al., 1999). 
Phagolysosomes are formed after the fusion of phagosomes with cellular acidic lysosomes. 
The multiple intracellular phagolysosomes eventually fuse together leading to the 
formation of a large unique vacuole. C. burnetii has adapted to the phagolysosomes of 
eukaryotic cells and is capable of multiplying in the acidic vacuoles. In fact, acidity is 
necessary for its metabolism, including nutrients assimilation and synthesis of nucleic 
acids and amino acids (Rodolakis, 2011). The ability of C. burnetii to grow and multiply 
within phagolysosomes and its propensity to establish persistent infection, are of central 
importance for the pathogenesis of the disease. The adaptation of C. burnetii to 
intracellular life is linked with acidic pH of its phagosome and both virulent and avirulent 
bacteria are found in phagosomes. Acidic pH allows the entry of nutrients necessary for C. 
burnetii metabolism and also protects bacteria from antibiotics by altering their activity 
(Hackstadt and Williams, 1981). Indeed Increasing pH with lysosomotropic agents such as 
chloroquine restores the bactericidal activity of doxycycline (Raoult et al., 2005). 
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The mechanisms of C. burnetii survival in phagolysosomes are still under study. Mo et al. 
(1995) and Akporiaye and Baca (1983) identified 3 proteins involved in intracellular 
survival: a superoxide dismutase, a catalase, and a macrophage infectivity potentiator 
(Cbmip). Redd and Thompson (1995) found that secretion and export of Cbmip was 
triggered by an acid pH in vitro. Later, studies by Zamboni and Rabonovitch (2003) 
demonstrated that growth of C. burnetii was reduced by reactive oxygen intermediates 
(ROI) and reactive nitrogen intermediates. 
In ruminants after primary multiplication in the regional lymphnodes, an ensuing 
bacteraemia lasts for at least 7 days at most 21 days and the organism then localizes in the 
mammary glands and the placenta of pregnant animals (Forland et al., 2010). The natural 
history of C. burnetii infection in cattle, sheep and goats is that a non-immune (often neo-
natal) animal is infected from the environment, often contaminated by parturient or other 
animals shedding the organism and it undergoes a primary infection  with weak clinical 
signs. However, the organism can persist after initial acute or subclinical disease, being 
shed in large numbers when a persistently infected female animal becomes pregnant. 
Experimental studies have shown that, during early pregnancy, the organism may be 
collected from the liver, spleen, kidney, bone marrow, lymph nodes and the intestine up to 
13 weeks of pregnancy. The placenta becomes positive only just before parturition (Harris 
et al., 2000). At the end of the pregnancy, the placenta allows the organism to multiply to 
high titles and at parturition it is shed in the placenta through the amniotic and other fluids. 
Aerosols are liberated and the environment can easily become contaminated with highly 
resistant bacteria. The level of IgG, climbs at this stage. In subsequent pregnancies, the 
animal does not excrete again or only at a low title. However, the bacteria may continue to 
be shed in the milk, particularly of cattle, for long periods of time (Woldehiwet, 2004). 
Also in animals C. burnetii infection may become chronic, like in humans. In goats C. 
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burnetii shedding was found at successive parturitions suggesting that goats could be 
chronically infected and that the multiplication of the organism may be reactivated during 
subsequent pregnancies (Berri et al., 2007). In chronically infected ruminants, it is not 
clearly understood how and where Coxiella persists in the non-pregnant period and which 
mechanism initiated the bacteria multiplication in the placenta. It is however known that 
pregnancy results in immunomodulation that may be responsible for the increase 
multiplication of the organism in the placenta (Polydourou, 1981). A significant correlation 
was found among C. burnetii antibody levels and the concentrations of cortisol, pregnancy-
associated glycoproteins (PAG), and plasma progesterone. These findings suggest that the 
C. burnetii infection can modify endocrine patterns throughout gestation and induce 
placental damage and diminishing PAG levels (Garcia-Ispierto, 2010).  
In humans after primary multiplication in the regional lymph nodes, haematogenous spread 
results in the organism infecting the liver, spleen, bone marrow, the reproductive tract and 
other organs. Acute infection is usually characterized by atypical pneumonia and hepatitis, 
and is followed by the formation of granulomatous lesions in the liver and bone marrow, 
with granulomatous hepatitis being the most frequent indication of infection with C. 
burnetii. The granulomatous lesions have a central open space and a fibrin ring and are 
referred to as doughnut granulomas (Tissot-Dupont and Raoult, 2007). The formation of 
granuloma is due to the activation of the cell mediated immunity and tissue granulomas are 
present only in patients with acute Q fever, where the clinical outcome is usually favorable, 
suggesting that granulomas play an important role in the resolution of Q fever (Faugaret et 
al., 2014). Immune control of C. burnetii is T-cell dependent but does not lead to C. 
burnetii eradication (Honstettre et al., 2004). C. burnetii DNA can also be found in 
circulating monocytes or bone marrow of people infected months or years earlier (Capo et 
al., 2003). 
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C. burnetii infection may become chronic in patients with predisposing conditions, 
including those with heart valve lesions, vascular abnormalities, and immunosuppression 
(Fenollar et al., 2001). The latency between acute and chronic infection may last from 
months to years (Capo and Mege, 2012). It is not clearly understood how and where 
Coxiella persists during this latency period. In a prolonged Q fever post infection fatigue 
syndrome (QFS), the bone marrow was identified as potential focus of C. burnetii infection 
from which placenta and other sites such endocardium may be seeded for recrudescent 
infection (Harris et al., 2000; Marmion et al., 2005). Once established, chronic Q fever is 
characterized by defective cell-mediated immunity, thus highlighting the major role of cell-
mediated immunity in the protection against C.burnetii (Angelakis E., Raoult D., 2010). 
During chronic Q fever the immune response is ineffective (Maurin and Raoult, 1999), and 
may also be harmful, causing leucocytoclastic vasculitis and glomerulonephritis (Rault, 
1990). C burnetii continues to multiply despite high concentrations of all 3 classes of 
antibodies (IgG, M, and A) to phase I and II bacteria. Lymphocyte counts and the CD4-to-
CD8 ratio are lowered (Sabatier et al., 1997). Organ biopsies do not show granulomas, but 
large vacuoles containing C burnetii can be detected in infected tissues, such as heart 
valves and liver and also in aneurysms (Maurin and Raoult, 1999). Monocytes from these 
patients are not able to kill C burnetii (Dellacasagrande et al., 2000), and do not migrate 
through the endothelium (Raoult et al., 2005). The most prominent lesion of chronic Q 
fever are endocarditis, aneurisms, osteomyelitis, chronic hepatis, pseudotumors of the lung 
or of the spleen (Tissot-Dupont and Raoult, 2007).  
 
1.4.2 Immune response 
Monocytes and macrophages are the major targets of C. burnetii and the intracellular 
survival of C. burnetii organisms requires the subversion of the microbicidal properties of 
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these cells (Capo and Mege, 2012). C. burnetii induces strong remodelling of the actin 
cytoskeleton when interacting with monocytes and macrophages via avβ3 integrins, with a 
final effect of reduction of the efficiency of bacteria uptakes (Capo et al., 1999). The 
internalization pathway is different for phase I (virulent), and phase II (avirulent) forms, 
because phase II attachment is mediated by both avβ3 integrins  and complement receptor 
CR3. Therefore Phase II internalization is more efficient, resulting in better multiplication, 
thus explaining why phase II bacteria grow more rapidly than phase I, resulting in a shift 
from phase I to phase II in the laboratory (Raoult et al., 2005). Virulent C. burnetii 
organisms stimulate transient reorganization of filamentous actin (F-actin) and the 
formation of pseudopodal extensions that, on one side are associated with phagocytosis 
impairment and on the other hand are required for virulent C. burnetii entry in 
mononuclear cells (Mege, 2007). The low efficiency of virulent bacteria uptakes is 
probably critical for the persistence of C. burnetii in monocytes and macrophages, but 
besides low bacterial uptake, also a relative alteration in cytokines production is necessary 
for the persistence of the bacteria (Capo and Mege, 2012). A key element in promoting the 
persistence of C. burnetii in mononuclear cells is the secretion of IL10. The production of 
this cytokines has been demonstrated to increase C. burnetii replication in monocytes, to 
down-modulate TNF production and to affect the migration of immune cells to peripheral 
tissues. Moreover high levels of IL10 secretion has been found in patients with chronic Q 
fever and murine models have confirmed the key role of this cytokine in bacterial 
persistence (Maurin and Raoult, 1999).  
Also Toll-like receptors (TLRs) play an important role in the immune response: TLR4, 
which recognizes lipopolysaccharides antigens (LPS), control the immune response against 
C. burnetii through granuloma formation and cytokines production, while TLR2, which 
recognizes peptidoglycan and lipopeptides, is involved in TNF and IFN-γ production 
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(Capo and Mege, 2012). The interaction of C. burnetii with macrophages, resulting in the 
reorganization of the cytoskeleton, depends largely from TLR4 and the C burnetii-
stimulated formation of pseudopodes is prevented by the absence of TLR4 (Mege, 2007). 
Honestettre et al. (2004) demonstrated, using TLR4-deficient mice, that TLR4 controls the 
inflammatory response to C. burnetii leading to the formation of granuloma, while it has 
no microbicidal competence. The role of TLR4 in the control of granuloma formation may 
result from the modulation of the production of cytokines such as IFN-γ and TNF, known 
to be required for granuloma formation. The engagement of TLR4 leads to the production 
of type 1 cytokines required for protection against intracellular microorganisms, in contrast 
to TLR2 engagement that favors the production of type 2 cytokines. Therefore TLR4 is 
involved in the uptake of virulent C. burnetii by macrophages and is necessary for the 
formation of protective granulomas and the production of IFN-γ and TNF, but do not 
control the microbicidal activity of macrophages that involves other defense mechanisms 
(Honestettre et al. 2004).  
Also TLR2 are involved in C. burnetii infection: Zamboni et al. (2004) showed that TLR2 
are involved in TNF and IFN-γ production and that TLR2 activation interferes with C. 
burnetii intracellular replication, as macrophages from TLR2-deficient mice were highly 
permissive for C. burnetii growth compared with macrophages from wild type mice. 
The activation of adaptive immune response in human is essential to cure C. burnetii 
infection. In primary infection the uptake of the virulent microrganism by macrophages 
and dendritic cells leads to the presentation of bacterial antigens to T lymphocytes and to 
the production by immune cells of IFN-γ and TNF, that induce the apoptosis of infected 
macrophages (Capo and Mege, 2012). In patients unable to mount a good IFN-γ response, 
like immunecompromized people or pregnant women, infected macrophages survives and 
their microbicidal activity is impaired, leading to a high risk to develop chronic Q fever 
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(Maurin and Raoult, 1999). The combination of IFN-γ production and granuloma 
formation in patients with primary C. burnetii infection suggests a Th1-type polarization of 
the immune response (Maurin and Raoult, 1999).  
The action mechanism of IFN-γ is due to the restoring of phagosome-lysosome fusion in 
infected macrophages, to the promotion of these cells apoptosis and to the down-
modulation of transferrin receptors, leading to a decreased assimilation of iron from the 
infected cells (Capo and Mege, 2012). Furthermore, during C. burnetii infection, 
monocytes exhibit a M1 type polarization, able to control bacterial replication, while in 
macrophages C. burnetii induces an atypical M2 profile, associated with the release of 
molecules like IL-10, that is unable to control bacteria replication. The secretion of IFN-γ 
has been demonstrated to reorients macrophages to a M1 proinflammatory polarization 
(Capo and Mege, 2012). 
Chronic Q fever is characterized by defective cell-mediated immunity, thus emphasizing 
the major role of cell-mediated immunity in the protection against C. burnetii. 
Lymphocytes from patients with Q fever endocarditis do not proliferate in response to C. 
burnetii antigen, in contrast to lymphocytes from patients with acute Q fever (Koster et al., 
1985).  
The role of humoral immune response in C. burnetii infection has not yet been completely 
clarified. The current immunological paradigm suggests that humoral response is more 
effective in extracellular bacterial infection while the major protective immune response 
against intracellular bacteria occurs in cell mediated immunity. Large amounts of 
antibodies are produced in humans and animals infected with C. burnetii. Antibodies 
develop within 3-4 weeks from the onset of the disease: in humans the majority of the 
antibodies after primary infection are directed against phase II antigens and a similar 
model account for the response to Q fever vaccination, while increased levels of antibodies 
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directed against phase I antigens are related to chronic infection (Capo and Mege, 2012). 
Immunoglobulin M antibodies reactive with phase II C. burnetii appear rapidly, reach high 
titers within 14 days and persist for 10–12 weeks (Maurin and Raoult, 1999). 
Immunoglobulin M antibodies reactive with phase I antigens are usually at a much lower 
titer during acute infection. Immunoglobulin G antibodies reactive with phase II antigens 
reach peak titers about 8 weeks after the onset of symptoms, while those reactive with 
phase I antigens develop only very slowly and remain at lower titers than antibodies to 
phase II antigens, even after a year. In chronic Q fever, where there is persistence of 
organisms, the IgG titers to phase I and phase II antigens may both be high, and the 
presence of IgA antibody to phase I antigen is usually, although not exclusively, associated 
with chronic infection (Angelakis and Raoult, 2009). 
In C. burnetii infection, a study from Humpres and Hinrichs (1981) showed that treatment 
of athymic mice with immune sera against C. burnetii had no effect on the bacteria 
replication within the spleen, suggesting that only cells mediated immunity plays a role in 
controlling the infection. On the other side two recent studies (Zhang et al, 2007; Shannon 
et al., 2009) demonstrated that vaccine induced antibodies are able to provide complete 
protection in immunocompetent mice when infected with C. burnetii. Several studies 
analyzed the ability of anti C. burnetii opsonizing antibodies to reduce the survival of the 
bacteria in mononuclear cells. These studies suggest that, although antibodies are able to 
increase the ability of phagocytes to uptake Ab-opsonized Coxiella, they did not affect the 
ability of phagocytes to control the organism replication (Zhang et al., 2012). Moreover 
Desnues et al. (2009) showed that macrophages incubated with C. burnetii cells opsonized 
with specific IgG antibodies, released higher amounts of IL10 and that C. burnetii 
opsonization increased bacteria replication. Briefly antibodies proved to protect naive mice 
from C. burnetii infection, but their activity is effective only if supported by the cell 
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mediate response that is essential for the clearance of C. burnetii infection (Zhang et al., 
2012). 
Few studies have been performed in animals concerning immune response and the great 
majority investigated the humoral immune response only in dairy cows. 
Böttcher et al. (2011) observed in an endemically infected dairy herd the presence of 3 
different patterns of antibody: phase I negative and phase II positive, phase I positive and 
phase II negative, phase I and phase II positive. The phase I negative and phase II positive 
was the predominant pattern found at the first sampling in cows 2–3 years old, but one year 
later there was an increase in the prevalence of the phase I and phase II positive pattern. 
This change in serological patterns could demonstrate a transition from acute to chronic 
infection. Another aspect that was highlighted in this study was that about 60 % of the 
cows older than 4 years remained seronegative despite the intensive shedding of C. 
burnetii in the herd and the frequent seroconversion in primiparous cows. This 
phenomenon was explained assuming that at least some of these multiparous cows built up 
an efficient cellular immunity with low or undetectable levels of antibodies (Böttcher et al., 
2011). Another abnormal pattern of humoral immune response in cattle is the presence of 
seronegative cows, shedding C. burnetii, as reported by several authors (Guatteo et al., 
2007; Rousset et al. 2009a; Boettcher et al., 2012). Guatteo et al. (2007) found that in this 
cows the shedding was sporadically or intermittent while cows with a high serological titer 
were persistent shedders. A possible explanation of this behavior is that also these cows 
had built up an efficient cellular immunity against C. burnetii, so shedding of the bacteria 
is only sporadic. 
Pregnancy has been considered by some authors (Böttcher et al 2011; Nogareda et al., 
2012) an important event in determining the outcome of infection by C. burnetii in cows, 
because during pregnancy, a shift of immunity towards TH2-activity with elevated levels 
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of immunosuppressive IL-10 occurs: TH2-activity drives the immune response towards an 
unfavorable direction to control an intracellular parasite like C. burnetii and IL-10-
mediated immune suppression could also activate C. burnetii in persistently infected cows 
during pregnancy. The hypothesis that pregnancy is an important trigger relies on non-
immune heifers at the time of first pregnancy (Böttcher et al., 2011). 
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1.5 CLINICAL SYMPTOMS AND PATHOLOGY 
 
1.5.1 Animals 
The natural history of C. burnetii infection in cattle, sheep and goats is that a non-immune 
(often neonatal) animal is infected from the environment, often contaminated by parturient 
or other animals shedding the organism and undergoes a primary infection with weak 
clinical symptoms. However, the organism can persist after initial acute or subclinical 
disease, being shed in large numbers when the persistently infected female animal becomes 
pregnant (Harris et al., 2000).  
There is very little information about the clinical signs of Q fever in domestic animals. Q 
fever clinical symptoms in animals as in humans are usually non-specific and often 
relatively mild. Despite the earlier reports of respiratory disease due to C. burnetii in 
sheep, goats and cattle (Babudieri, 1953; Aitken, 1989), the only clinical disease of 
domestic animals attributable to C. burnetii is abortion in naturally and experimentally 
infected sheep, goats and cattle (Woldehiwet, 2004). Abortion is more frequent in goats 
and sheep than in cows, while infection in dairy cattle is considered to reduce fertility 
(Lang et al., 1991). All pregnant ruminants are highly susceptible to infection and the 
abortions occurs only at the first parturition after infection, while the following gestations 
terminated normally without any reproductive failures. In goats, C. burnetii can induce 
pneumonia as well as abortion with stillbirth and delivery of weak kids being the most 
important clinical signs (Berri et al., 2007). Q fever abortions in caprine herd are more 
important than in sheep flocks, affecting sometime up to 90% of females (Palmer et al., 
1983). Furthermore in goats, unlike in sheep, pregnancy subsequent to C. burnetii abortion 
may not be carried to term (Berri et al., 2007). 
38 
 
An investigation by Berri et al. (2007) also showed that C. burnetii was excreted in birth 
products of either affected goats or females that had normal delivery and that they 
continued to shed the organism long after the outbreak. Although most of the females had a 
normal delivery, C. burnetii was highly excreted at the second kidding season as the 
bacteria were found in vaginal swabs taken from 94% of the tested goats. In addition, this 
study showed that goats shed C. burnetii at successive parturitions suggesting that these 
goats could be chronically infected (Berri et al., 2007). 
In chronically infected ruminants, it is not clearly understood how and where C. burnetii 
persists in the non-pregnant period and which mechanism initiated the bacteria 
multiplication in the placenta. Similar latent persistence and recrudescence of Q fever 
occurs in humans but the organ site for latent infection is still unknown (Berri et al., 2007). 
However, in a prolonged Q fever post infection fatigue syndrome (QFS), the bone marrow 
was identified as potential focus of C. burnetii infection from which placenta and other 
sites such endocardium may be seeded for recrudescent infection (Harris et al., 2000; 
Marmion et al., 2005). 
In dairy cattle the others clinical symptoms reported in literature further than abortion are 
placenta retention, metritis, and mastitis. Positive correlation between seropositivity to C. 
burnetii and placenta retention was found by Lopez-Gatius et al. (2012).  
Some authors have reported an increased prevalence of metritis in seropositive animals (To 
et al., 1998), while others didn't detect such relationship (Muskens et al., 2011). 
Considering that the detection of C. burnetii in the uterus may often happen in healthy 
animals, also this finding in case of metritis could not be so resolutive to demonstrate a 
link between metritis and C. burnetii infection.  
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In a study performed on an infected dairy herd in USA, C. burnetii shedding in milk was 
associated with chronic subclinical mastitis in cows demonstrated to be free of infection 
caused by common aerobic mastitis pathogens (Barlow et al, 2007). 
Significant macroscopic pathological lesions reported in animals naturally infected with C. 
burnetii are rare. Usually there are no macroscopic fetal lesions, but the infected placenta 
can exhibit the following histopathological features: infiltration of the chorionic stroma by 
mononuclear cells, necrosis of chorionic trophoblasts and focal exudation of fibrin and 
neutrophils. A significant statistical association was found between these lesions in cases 
of bovine abortion and the presence of C. burnetii demonstrated by immunohistochemical 
(IHC) test (Bildfell et al., 2000). In another study (Hansen et al., 2011) the microscopic 
examination of cotyledonary sections from infected placenta showed only minor lesions or 
absence of lesion at all. The findings suggest that significant C. burnetii associated lesions 
of the bovine placenta at parturition are rare. The absence of severe lesions indicates that 
placental dysfunction is not a feature of late term placental coxiellosis in cattle and this 
may explain why increased stillbirth rates have not been reported in C. burnetii infected 
cattle herds (Hansen et al., 2011). 
In pregnant goats after experimental infection necrotic and suppurative placentitis were 
observed from day 130 of gestation. The placenta observed after the abortion were 
characterized by multifocal necrosis of the chorionic epithelium and severe suppurative 
inflammation at the base of the villi. The inflammatory exudate was composed mainly of 
neutrophils, with occasional macrophages (Sanchez et al., 2006). In the same study the 
only fetal organ in which lesions were observed was the liver, which usually showed mild-
to-moderate perivascular hepatitis with neutrophils and lymphocytes surrounding the 
vessels. Neutrophils sometimes formed foci or appeared as a diffuse infiltrate in the hepatic 
parenchyma.  
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Other fetal lesions, described in literature are the presence of peribronchiolar, renal 
medullary and hepatic portal lymphocytic aggregates (McGavin and Zachary, 2006).  
 
1.5.2 Humans 
The main characteristic of Q fever in humans is its clinical polymorphism, therefore the 
diagnosis is quite difficult and a laboratory confirmation test is needed.  
Gender and age also affect the expression of C. burnetii infection. Men are symptomatic 
more often than women despite comparable exposure and seroprevalence (Tissot-Dupont 
and Raoult, 1992; Maltezou and Raoult, 2002). Moreover, the prevalence of clinical cases 
in children significantly increases with age and symptomatic Q fever occurs more 
frequently in people over 15 years old (Maltezou and Raoult, 2002). 
Acute Q fever 
The incubation period has been estimated to be approximately 20 days (range, 14–39 
days). There is no typical form of acute Q fever and the clinical signs vary greatly from 
patient to patient. The most frequent clinical manifestation of acute Q fever is probably a 
self-limited febrile illness (91%) which is associated with severe headaches (51%), 
myalgias (37%), arthralgias (27%) and cough (34%) The main symptoms fever, pulmonary 
signs, and elevated liver enzyme levels can coexist. Atypical pneumonia is also a major 
clinical presentation and abnormal chest X rays can be found in 27% of the patients 
(Tissot-Dupont et al., 2007). Atypical pneumonia is one of the most commonly recognized 
forms of acute Q fever. Most cases are clinically asymptomatic or mild, characterized by a 
nonproductive cough, fever and minimal auscultatory abnormalities, but some patients 
present with acute respiratory distress. Pleural effusion can also appear (Raoult et al., 
2005). 
Hepatitis is also very frequent in predominately 3 forms: an infectious hepatitis-like form 
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of hepatitis with hepatomegaly but seldom with jaundice, clinically asymptomatic 
hepatitis, and prolonged fever of unknown origin with characteristic granulomas on liver 
biopsy. Q fever hepatitis is usually accompanied clinically by fever and less frequently by 
abdominal pain, anorexia, nausea, vomiting, and diarrhea (Marrie and Raoult, 1987; 
Marrie, 1988). 
Cardiac involvement is found in 2% of the acute Q fever cases and myocarditis is the 
leading cause of death (Fournier et al., 2001). 
Skin lesions have been found in 5–21% of Q fever patients in different series. The Q fever 
rash is nonspecific and may correspond to pink macular lesions or purpuric red papules of 
the trunk (Maurin, 1999). 
Among neurological symptoms 3 major entities associated with Q fever have been 
described: meningoencephalitis or encephalitis; lymphocytic meningitis and peripheral 
neuropathy (Bernit et al, 2002).  
According to the literature, 60% of infected patients are asymptomatic, while 20% develop 
mild symptoms. The remaining 20% (40% symptomatic) present with a self-limiting flu-
like illness with some more severe manifestations including high fever, severe headache, 
night sweating, nausea, diarrhea, pneumonia,, hepatitis, pericarditis, myocarditis, 
neurological symptoms and weight loss (Mertens and Samuel, 2007; Angelakis, 2010). 
The acute illness spontaneously resolves after 2-6 weeks. However the organism may 
persist in the bone marrow and the disease can reactivate after appropriate stress. Acute Q 
fever may develop into chronic illness in 2% of patients (Frode-Forland et al.,, 2010) and 
can express itself in different forms (Wildman et al., 2002a; Wildman et al., 2002b; 
Karakousis et al., 2006). 
Chronic Q fever 
Chronic Q fever may develop many months to years after initial infection. It occurs almost 
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exclusively in patients with predisposing conditions, including those with heart valve 
lesions, vascular abnormalities, cancer and immunosuppression. Pregnant women are at 
high risk of a developing chronic infection (Fenollar et al., 2001). Chronic Q fever 
manifests mainly as bacterial culture negative endocarditis in up to 48% of cases 
(Houpikian and Raoult, 2005). Recrudescent granulomatous infection can also occur. 
Another long term effect of Q fever is the post-Q fever fatigue syndrome (QFS). Up to 
60% of patients may experience QFS symptoms which can persist for 6-12 months and 
then spontaneously resolve (Ayres et al., 1998). 
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1.6 DIAGNOSIS 
 
1.6.1 Animals 
Diagnosis of Q fever based on clinical symptoms or post-mortem examination is almost 
impossible due to unspecific or missing symptoms or lesions caused by the disease. For 
this reasons the laboratory diagnosis is the only reliable way to confirm the presence of C. 
burnetii in domestic or wild animals. Several assays have been described for the diagnosis 
of C. burnetii in animals, including both direct identification of the agent and serological 
testing. 
Direct identification of the agent 
The most useful samples for the detection of C. burnetii in livestock are vaginal mucus, 
placenta or foetal tissue (Sidi-Boumedine et al., 2010). Samples should be collected from 
aborted fetuses, placenta and vaginal discharges soon after abortion or parturition. Milk, 
colostrum and feces samples can also be taken but they are not reliable to detect clinically 
affected herds or flocks (Sidi-Boumedine et al., 2010). For direct identification of C. 
burnetii, sampling should be targeted at pregnant animals either giving birth normally or 
aborting. This is because infected female animals, even with normal parturition, are high 
shedders of C. burnetii into birth products (Arricau-Bouvery et al., 2003). The sampling 
should be carried out as soon as possible after parturition or abortion and more precisely 
within a week because the shedding level of the bacteria decreases sharply after that time 
(Sidi-Boumedine et al., 2010), also if C. burnetii shedding may persist over several months 
(Kim et al., 2005; Berri et al., 2007). 
Conventional staining techniques (Stamp, Gimenez, Macchiavello, Giemsa and modified 
Koster) are available within the context of the diagnostic of abortion and are used on 
tissues from fetus or placenta and on vaginal discharge. These tests have low diagnostic 
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sensitivities and specificities. They need attention because C. burnetii can be confused with 
Chlamydophila abortus or Brucella spp (EFSA, 2010). 
Detection of C. burnetii can also be achieved with  IHC. The method uses either indirect 
immunofluorescence or an immunoperoxidase assay, using polyclonal C. burnetii 
antibodies (either a well characterized antiserum of human origin or a specific antiserum 
produced in rabbits or guinea pigs). An anti-species (human, rabbit or guinea pig) anti-IgG 
conjugate labeled with Fluorescein isothiocyanate (FITC) or peroxidase is then used to 
visualize the bacteria (EFSA, 2010). No specific antibodies for IHC are commercially 
available (OIE, 2015). IHC in placenta was used by Hansen et al. (2011) with paraffin-
embedded section that included a central area of the cotyledon, margin and adjacent 
chorion laeve. Antibodies against C. burnetii were produced by intraperitoneal inoculation 
of mice with Nine Mile strain and immunoperoxidase used to stain bacteria.  
Isolation of C. burnetii could be performed from fetuses, placenta, vaginal swabs, milk and 
feces.  
Samples can be refrigerated at +4° C before shipping to the laboratory only if they are 
delivered at least 24 hours after collection, otherwise they should be frozen at -18° C 
immediately after sampling and then shipped to the laboratory (Vicenzoni and Barberio, 
2013). 
Isolation of C. burnetii can be done by cell or embryonated chicken egg culture. Such 
isolation is possible when microscopic examination indicates a large number of C.burnetii 
and a low level of contamination. With heavily contaminated samples, such as placentas, 
vaginal discharges, feces or milk, the inoculation of laboratory animals may be necessary. 
Mice and guinea pigs are the most appropriate (EFSA, 2010). C. burnetii is classified as a 
biological agent of level 3: for this reason all methods involving manipulation and 
replication of live bacteria should be performed in level 3 containment facility (WHO, 
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2004). However this kind of facility is available only in few laboratories so isolation is 
usually not adopted in routine diagnostic, but only in specific studies that require the 
isolation of the microrganism.  
Currently the PCR is one of the most sensitive and rapid means for the direct detection of 
C. burnetii and the identification of shedding animals. PCR is adapted to a wide range of 
samples like vaginal discharge, abortion material, feces and milk (bulk or individual). It is 
sensitive and rapid and is becoming increasingly common in diagnostic laboratories (Berri 
et al., 2000; Nicollet and Valognes, 2007).  
The level of detection of conventional PCR is related to the sample under investigation (1–
500 bacteria/ml of milk; 1 bacteria/mg of feces). Several target genes have been used, such 
as the multicopy insertion sequence IS1111 or single copy genes encoding various proteins 
(e.g dismutase [sodB]; com1 encoding a 27 kDa outer membrane protein; heat shock 
proteins [htpA and htpB]; isocitrate dehydrogenase [icd]; macrophage infectivity 
potentiator protein [cbmip]) (EFSA, 2010). 
The development of real-time PCR technology has recently allowed the quantification of 
C. burnetii in samples using a logarithmic scale (Pfaffl, 2001). Real-time PCR techniques 
have been described by several authors (Stemmler and Meyer, 2002; Kim et al., 2005; Klee 
et al., 2006;).  
Real-time PCR is considered the most sensitive and rapid mean for the identification of 
animals shedding C. burnetii. The specificity levels of different laboratories for the 
detection of C. burnetii DNA in different spiked matrices (PBS, placenta, milk and aborted 
fetuses) and of different protocols are comparable (Duquesne et al., 2008; Jones et al., 
2011). Regarding sensitivity, PCR tests directed against the multiple-copy target IS1111 
(real-time and conventional) were found to be superior to tests detecting single-copy genes. 
Although a threshold for quantitative real-time PCR is not officially approved at 
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international level  a group of French experts has suggested that abortion in ruminants 
should be confirmed to be caused by C. burnetii when at least 104 bacteria per gram of 
placenta or vaginal swabs are detected (Touratier et al., 2007). In tissues or stomach 
contents from aborted foetuses, the same group considered that a positive result by 
quantitative PCR is sufficient to diagnose Q fever as the origin of abortion. For pooled 
samples, the proposed threshold is 103 bacteria per pool. These thresholds are indicative 
and may be revised especially if new scientific information becomes available (Sidi-
Boumedine et al., 2010).  
Molecular characterization of strains is crucial to compare genotypes isolated from 
different animal species, to trace outbreaks and to assess relationships between genotype 
and virulence of the strains with a special regard to public health (Ceglie et al., 2015).  
Several typing methods have been used for the characterization of C. burnetii strains, 
including restriction endonuclease of genomic DNA (Hendrix et al., 1991), pulsed-field gel 
electrophoresis (Heinzen et al., 1990; Jager et al., 1998).  
More recently the availability of complete genome sequences has allowed to apply to this 
bacterium many highly discriminatory methods, mainly based on molecular techniques like 
multispacer sequence typing (MST), IS1111-element positioning, infrequent restriction 
site-PCR (IRS-PCR), multiple loci variable number of tandem repeat analysis (MLVA) 
and  single nucleotide polymorphism (SNP) (Vergnaud and Pourcel, 2006; Massung et al., 
2012). Recently, researchers from different countries have applied the MLVA method to 
C. burnetii strains because of its quite high discriminatory power and its applicability 
either to isolated bacterial strains or directly to DNA extracted from clinical samples 
(Arricau-Bouvery, 2006; Svraka, 2006). French researchers identified within the C. 
burnetii genome a total of 17 markers different minisatellite and microsatellite to be used 
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in MLVA genotyping in 2 successive panels. A third panel was implemented during the 
Dutch Coxiella outbreak, involving 6 microsatellites (Tilburg, 2012). 
Indirect identification of the agent 
Q fever serology is used for different veterinary research objectives throughout the world, 
but is far from being standardized. There is no officially prescribed test for the serological 
diagnosis of Q fever. Serological antigens are based on the two major antigenic forms of C. 
burnetii: phase I, obtained from spleens after inoculation of laboratory animals and phase 
II, obtained by repeated passages in embryonated eggs or in cell cultures. Currently 
available commercial tests allow the detection of phase II or of both phases II and I anti-C. 
burnetii antibodies (OIE, 2015). 
Among the various techniques that can be employed, the 3 most common are CFT, IFA 
and ELISA. 
The CFT was considered the reference test for historical reasons but its diagnostic 
sensitivity was highly variable (Roest et al., 2011). Several studies showed that the CFT 
has a low relative sensitivity, but conversely it has a high specificity for the high levels of 
anti-C. burnetii antibodies generated in a Q fever aborted herd or flock (Rousset et al., 
2007; Kittelberger et al., 2009; Horigan et al., 2011; Natale et al., 2012; Emery et al., 
2014). 
In goats a study by Rousset et al. (2007) showed that CFT was less performing than ELISA 
and IFA, giving a large proportion of dubious results (71%), whereas these same sera gave 
positive results with ELISA. Moreover, no association was found between positive (or 
strongly positive) CFT results and Q fever abortion, therefore the authors did not 
recommend the use of this test for serological screening, because of its low sensitivity. 
Several reason could explain the poor test performance of CFT. The antigen used for CFT, 
obtained from Nine Mile strain, utilizes only phase 2 antigens (Porter et al., 2011). 
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Moreover CFT can fail to detect antibodies when anti-complementary substances are 
present in the tested sera and can't detect all IgG subclasses. In ruminants for example only 
IgG1 antibodies are known to fix the complement in CFT (Micusan and Borduas, 1977; 
Schmeer, 1985) and the presence of IgG2 and IgM antibodies can suppress complement 
fixation by IgG1 antibodies (Schmeer, 1985). 
The IFA adapted as a micro-immunofluorescence technique is the current method for the 
serodiagnosis of Q fever in humans (Tissot-Dupont et al., 1994). Both phase I and phase II 
C. burnetii antigens are used; phase II antigen is obtained by growing C. burnetii Nine 
Mile reference strain in cell culture, while phase I antigen is obtained from the spleens of 
laboratory animals. The test can be adapted to the use in veterinary medicine by replacing 
the human conjugate with a conjugate adapted to the animal species (OIE, 2015). IFA 
showed in a study on goats (Rousset et al., 2007) a better sensitivity than CFT and a good 
agreement with ELISA, both qualitatively, in the detection of positive animals and 
quantitatively, in term of correlation between IFA titers and ELISA optical densitiy . The 
study also reported that IFA results obtained on sera of aborting goats and of non-aborting 
goats were significantly different and were associated with occurrence of abortion. 
Currently, IFA is not commercially available for animals so the test should be prepared in 
house following the OIE method description. Therefore IFA in respect to ELISA has the 
disadvantage of being less reproducible between operators and laboratories (OIE, 2015).  
ELISA is the most used test in animals for the detection of anti-C. burnetii antibodies 
because is a sensitive technique, easy to perform and standardize.  
The ELISA is preferred to IFA and CFT, particularly for veterinary diagnosis, because it is 
convenient for large-scale screening and the most robust. Ready-to use kits are 
commercially available and can detect mixtures of anti-phase I and II antibodies (OIE, 
2015).  
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The antigens present in commercial ELISA are of two possible origins: antigens of the 
American Nine Mile strain of C. burnetii isolated from an endogenous tick, or antigens of 
a strain originating from infected European domestic ruminants. ELISA kits coated by the 
latter antigens are more sensitive and are advised for serological diagnosis (Rodolakis, 
2006). The commercial ELISAs available for veterinary diagnostic purposes detect total 
antibodies and do not differentiate anti-phase 1 and anti-phase 2 antibodies but a prototype 
with PhI- and II antigens coated separately is produced on demand by Ideex (Boettcher et 
al., 2011).  
The ELISA commercial kits currently available for the diagnosis of Q fever in ruminants 
are 3. Comparative analyses of available serological methods have been conducted during 
a ring trial assessments as part of a EU-funded, Framework 6 project. The IFA and 
commercially available ELISAs were each reproducible, with comparable diagnostic 
sensitivity (EFSA, 2010). 
The analytical sensitivity of all the different ELISA was found to be 8-16 times higher than 
that of the best CFT (Roest et al., 2011). Based on recent work, it was found that two 
commercial ELISAs can display different diagnostic sensitivities (81 and 95%, 
respectively) using a panel of sera from cattle, goat and sheep (Kittelberger et al., 2009).  
In goats a strong association between abortion and the occurrence of strongly positive 
ELISA results was demonstrated when sera were obtained from goats 15 days after the 
abortions and not later (Rousset et al., 2007). A study performed in Poland on ruminants 
(cattle, sheep and goats) demonstrated a moderate relationship between the identification 
of C. burnetii in fetus or placenta by real-time PCR, and ELISA positive results (r = 0.37–
0.48) (Niemczuk et al., 2014), while in a similar study performed in Italy a poor 
relationship was found (r = 0,01-0,16) (Natale et al., 2012).  
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A study performed on dairy cattle showed that persistent shedders cows had mainly a 
persistently highly seropositive status and that around 50% of persistently highly 
seropositive cows were found to be persistent shedders, while non highly seropositive 
cows were mainly either non- or sporadic shedders (Guatteo et al., 2006). 
Diagnostic approach to the disease 
The serological methods are useful for carrying out preliminary surveys of infection at 
herd level but they do not allow for the identification of C. burnetii shedding animals. 
When the positive serological results are found at herd level, the PCR is the method of 
choice to trace shedders. However, it should not be forgotten that if there is suspicion of 
infection or shedding of C. burnetii despite the absence of serological response, the test for 
pathogen detection (PCR or culture) should be performed (Niemczuk et al., 2014), because 
a significant proportion of animals shedding C. burnetii bacteria and even some Q fever 
aborted animals, are found to be seronegative (Guatteo et al., 2007; Rousset et al., 2007; 
Rousset et al., 2009a; de Cremoux et al., 2012a).  
None of the 3 serological available tests can be used to accurately discriminate an abortion 
case from a normal delivery at individual level. For these reasons Q fever diagnosis in 
animals should not rely on a unique diagnostic approach. The global clinical and 
epidemiological context must be taken into account as well as the limitations of diagnostic 
assays (Porter et al., 2011). 
In case of suspect the diagnosis of Q fever should involve the use of multiple techniques 
and can be interpreted validly only at herd or flock level.  
In order to identify C. burnetii, sampling should be performed on pregnant animals either 
giving birth normally or aborting. This is because infected female animals, even with 
normal parturition, are high shedders of C. burnetii into birth products (Arricau-Bouvery et 
al., 2003). C. burnetii shedding may persist over several months (Berri et al., 2005; Kim et 
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al., 2005). However, the shedding level of the bacteria decreases after parturition or 
abortion. Thus, sampling should be carried out within the week following abortion or 
parturition. The identification of the presence of the bacteria in the vaginal mucus of 
animals having aborted, or in their foetuses, by molecular methods, will then be more 
reliable. (Sidi-Boumedine et al., 2010). 
The serological analyses for the diagnosis of Q fever should be based  mainly on the 
ELISA test. A minimum number of 6 animals having aborted or shown reproductive 
problems should be taken. These animals should include multiparous and primiparous 
females which experienced abortions between at least 15 days to a maximum of 3 weeks 
before. Serology should be used as a complement to the PCR and carried out, preferably, 
by means of a test using antigens from a ruminant C. burnetii isolate (Sidi-Boumedine et 
al., 2010). 
 
1.6.2 Humans 
Q fever clinical symptoms in humans are usually non-specific and often relatively mild; 
hence, classical differential diagnosis must be supported by laboratory tests for accurate 
diagnosis of clinical disease. For the direct and indirect diagnosis in humans the methods 
used are the same described for animals, but the main difference is that in human medicine 
the diagnosis of Q fever is based on serology, which allows for differentiation between 
acute and chronic cases (Tissot-Dupont and Raoult, 2007). 
Serology in humans can differentiate between acute and chronic infection of C. burnetii 
because phase I and phase II antigens vary depending on the clinical progression of 
infection. Each phase has a different antigen profile:  
 in acute Q fever, the immune response is primarily driven by IgM and IgG 
antibodies directed against the avirulent form of C. burnetii (phase II).  
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 in the chronic form, IgG and IgA antibodies predominate and are directed against 
both the virulent and avirulent forms of bacteria (phase I).  
Acute infection is therefore characterized by elevated phase II antibody levels and it is 
generally first detectable after the second week of illness.  
In chronic Q fever, typically the opposite is true: phase I antigens significantly 
predominate over phase II.  
This happens because antibodies to phase I antigens of C. burnetii generally require longer 
to appear and indicate continued exposure to the bacteria. Thus, high levels of antibody to 
phase I in later specimens, in combination with constant or falling levels of phase II 
antibodies and other signs of inflammatory disease, suggest chronic Q fever. Antibodies to 
phase I and II antigens have been known to persist for months or years after initial 
infection (Maurin and Raoult, 1999). 
The most commonly used serological methods are, like in veterinary medicine: 
 ELISA,  
 CFT 
 IFA. 
IFA is commonly considered the reference diagnostic test and is the most frequently used 
worldwide (Tissot-Dupont and Raoult, 2007). It is accurate, highly sensitive, and specific 
(Fournier et al., 1998).  
Both phase I and phase II C. burnetii Nine Mile strain are used as antigens and antibodies 
of the IgG, IgM, and IgA subclasses can be determined. Sera are screened by 
microimmunofluorescence at a1:50 dilution with phase II antigens. Positive sera found on 
screening are serially diluted and then tested on both phase II and phase I antigens for the 
presence of IgG, IgM, and IgA (Maurin and Raoult, 1999). 
A titer > 200 for IgG and > 50 for IgM against phase II antigen indicate a recent Q fever 
infection, while an IgG titer > 800 against phase I antigen suggests chronic infection 
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(Fournier et al, 1998). IFA titers usually reach their maximum levels 4 to 8 weeks after the 
onset of acute disease and then decrease gradually over the following 12 months. The 
persistence of high levels of anti-phase I antibodies or the reappearance of antibodies after 
treatment my signal the development of chronic infection (Tissot-Dupont and Raoult, 
2007). 
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1.7. DISEASE CONTROL 
 
There are 3 broad measures to limit transmission and spread of directly transmissible 
infections in populations: reducing the adequacy of contact between individuals (animal-
animal, animal-human, human-human), reducing the proportion of the population 
susceptible through vaccination and decreasing the infectivity of infected individuals 
through vaccination or other medical treatment (EFSA, 2010). All 3 measures should be 
implemented to control the spread of C. burnetii infection. The first type of measure is 
defined as direct prophylaxis, while the second and the third are described as indirect 
prophylaxis. 
It should be highlighted that control measures for C. burnetii can only be effectively 
implemented if cases are detected and confirmed. This requires systematic and reliable 
classification of units/farms as cases. The basis for such a classification is a commonly 
agreed case definition. Case detection can be based on suspect case reporting (passive 
surveillance) or screening (active surveillance) (EFSA, 2010). 
Then the choice of a Q fever control strategy will depend on the overall goal of the control 
effort. This could, for example, be limited to avoiding severe cases or focus on problem 
farms, or at the other end of the spectrum, attempt complete eradication of C. burnetii 
infection in the entire population (EFSA, 2010).  
 
1.7.1 Direct prophylaxis measures 
The main concept behind direct prophylaxis is that the optimal control strategy may 
require a combination of several control interventions. This control strategy should be 
applied through measures to: 
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 Reduce the number of contacts per unit time. A broad range of measures are 
commonly applied to limit contact during animal disease control, including 
quarantine, test and slaughter, livestock movement control, changes in farm 
management etc. 
 Reduce the transmission potential per contact. Due to the feature of the infectious 
agent, it is generally difficult to influence the transmission potential within 
populations. However, these measures can be very important to limit the 
transmission potential per indirect contact between different flocks (hygienic 
measures). 
 Reduce the number of different farms in contact through trade restrictions (EFSA, 
2010). 
All these measures are not specific to Q fever only and the efficacy of each to reduce the 
infectious pressure or the C. burnetii transmission between animals and herds remains 
unknown. Case control studies allowing the identification of risk factors for Q fever 
outcome may not be reliable enough, due to the uncertainty about the true status of the 
control. A survey conducted in almost 100 infected dairy herds reported 2 main factors 
associated with an increase of seroprevalence: the introduction of more than 10 animals in 
the herd per year and the absence of disinfection of the calving pen after each calving 
(Taurel et al., 2009). 
Control measures should pay attention to the bedding material as a source of C. burnetii 
transmission among animals and from animals to humans, as described in several studies 
(Manfredi_Selvaggi, 1986; Arricau-Bouvery et al., 2001; Berri et al., 2004; Starnini et al., 
2005). In The Netherlands, spread of manure from infected herds was forbidden for at least 
90 days after suspicion of infection (Schimmer et al., 2008). The effectiveness of this 
measure must be evaluated and modified if necessary. Arricau-Bouvery et al. (2001) 
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performed decontamination of feces of experimentally infected goats with calcium 
cyanamid. However there are considerable differences in methods of manure management, 
consequently a specific standardized protocol has not yet been established for bedding 
manure treatment and decontamination.  
The following systems were assessed for effectiveness: 
 Deep litter systems, where goats are kept indoors on straw litters, straw is added 
regularly and removed only 3-4 times a year. The manure is usually moved to 
another location in or out of the farm. 
 Slurry treated with cyanamide calcium, 
 Manure composting for a period of time with or without covering (EFSA, 2010). 
Composting is a manure fermentation process that kills bacteria as the temperature rises. 
Traditional composting consists in piling manure within concrete walls and fermentation 
for 3 months. The inside temp is estimated to be a minimum of 50° C and this process will 
lead to a minimum of 4.3x10-7 reduction of C. burnetii. 
Manure must be covered and composted or treated with lime or calcium cyanamide 0.4% 
before being spread on the field; spreading of manure should never be performed when the 
wind blows (Arricau-Bouvery and Rodolakis, 2004). 
Abortions have been identified as an important risk factor for herd or flock status. 
Consequently, husbandry practices that control the exposure of animals to infectious doses 
of C. burnetii, such as segregation of areas for calving, lambing and kidding as well as 
removal of placenta and abortion materials, are useful to reduce bacterial exposure (EFSA, 
2010).  
The removal of these materials that have the potential to contain very high numbers of C. 
burnetii to specific rendering plants could reduce the environment contamination. The 
parturition pens must be disinfected as well as every utensil used for delivery (Arricau-
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Bouvery and Rodolakis, 2005). 
In the context of Q fever, the introduction of infected animals into naïve herds could be 
avoided if there were control of movement of animals of defined status between herds of 
defined status. However, this strategy is reliant on the reliable classification of animals and 
herds (for example, a farm-level certification system including testing scheme, cut offs, 
status definition etc). Given the diagnostic quality of currently available diagnostic tests 
however, considerable uncertainty is likely to remain as to the true status of an animal or 
herd (EFSA, 2010). 
A number of Q fever outbreaks in humans have been associated with  the shearing of sheep 
(Hellenbrand et al., 2001; Hellenbrand et al., 2005). Sheep wool can be heavily 
contaminated with infected birth products. Dust containing C. burnetii is produced during 
shearing and bacterial DNA can be found in the air of barns where sheep have been shorn 
(Schulz et al., 2005). In such situations, shearing personnel should wear protective filter 
masks and the fleece should be kept wet or even disinfected. (EFSA, 2010). 
Drinking milk containing C. burnetii can result in sero-conversion although it remains 
unclear as to whether, and if so, to what extent, clinical disease can result from the 
consumption of milk or dairy products or of other foods containing C. burnetii (EFSA, 
2010). Therefore pasteurization at 72 °C during 15'' or sterilization of milk from infected 
flocks is regularly recommended even if the oral route is not the main one (Arricau-
Bouvery and Rodolakis, 2005). 
 
1.7.2 Indirect prophylaxis measures 
Vaccination 
Current vaccines used in humans and animals include formalin-killed, whole-cell vaccine 
preparations (WCV) (Marmion et al., 1990) and chloroform methanol-extracted bacterial 
residue (CMR) (William et al, 1986; Waag et al., 1997). A WCV from the Henzerling 
58 
 
strain (Q vax, CSL Limited, Parkville, Victoria, Australia) has been commercially 
available and used for human vaccination in Australia since 1989 (Arricau-Bouvery and 
Rodolakis, 2005). The vaccine has been licensed in Australia to protect at-risk 
slaughterhouse employees and veterinary professionals. The vaccine can only be given to 
people not previously in contact with C. burnetii, as vaccinating subject that have already 
mounted an immunological response may lead to serious adverse reaction like systemic 
symptoms of inflammation. In the Netherland, during the epidemic  of 2007-2011, 1354 
people were vaccinated, all from the defined high risk patient group, people with heart or 
severe vascular disease (Van der Hoek et al., 2012). 
In animals the most effective vaccines are those composed of inactivated whole phase I 
bacteria (Arricau-Bouvery and Rodolakis, 2005).  
An inactivated non-adjuvanted phase I C. burnetii antigen Nine Mile strain vaccine 
(Coxevac, CEVA Santé Animal, France) is available for goats and cattle in Europe.  
In goats the efficacy of vaccination with phase I and phase II vaccines was compared, 
using this phase I (COXEVAC™) vaccine and a phase II vaccine (CHLAMYVAX FQ™), 
in pregnant animals, experimentally infected with a dose of C. burnetii sufficient to cause 
abortion or premature birth in 85% of the goats in the control group (Arricau-Bouvery et 
al., 2005). the phase I vaccine significantly protected goats against the development of C. 
burnetii infection causing abortions, as it reduced placental colonization, eliminated milk 
shedding and strongly reduced vaginal and fecal shedding of C. burnetii particles. In 
contrast, the phase II vaccine did not showed any difference compared to the control group 
(Arricau-Bouvery et al., 2005). 
Vaccination with Coxevac is targeted in all goats >3 months of age and should be 
performed at least 3 weeks prior to breeding (EMA, 2010). Booster vaccines are 
recommended every 280 days thereafter, but the exact duration of immunity has yet to be 
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determined (de Cremoux et al., 2012b). The immunogenicity of commercially available 
vaccines in open does and ewes may be more effective than in those pregnant for long-
term control of within-herd C. burnetii spread (Porter et al., 2011). However, the efficacy 
to prevent shedding from infectious animals needs to be assessed if vaccination is to be a 
method of public health intervention.  
In a systematic review and metanalysis about phase I vaccine (O'Neill et al., 2013) all 
publications reviewed but one (Hogerwerf et al., 2011) reported preventive vaccination 
exclusively to reduce the risk of shedding or clinical effects of C. burnetii infection 
following vaccination. During the Dutch Q fever outbreak, Hogerwerf et al. (2011) 
reported farms vaccinated reactively to reduce shedding and clinical effects or to prevent 
infection or subsequent clinical effects. 
Previous studies have shown that shedding is greatest at the first and second parturitions 
after infection in both goats and sheep, with most animals becoming infected in the first 
year of life (Hogerwerf et al., 2011; Porter et al., 2011).  
Vaccination with the phase I vaccine was also associated with prevention and/or reduction 
of shedding in ruminants (Hogerwerf et al., 2011), especially when applied on primiparous 
and/or susceptible goats (De Cremoux et al., 2012b) or susceptible non-pregnant dairy 
cows (Guatteo et al., 2008). Non-pregnant and uninfected dairy cows when vaccinated had 
a 5 times lower probability of becoming a shedder than an animal receiving a placebo. On 
the contrary cows vaccinated when pregnant had a similar likelihood of becoming shedder 
as an animal receiving the placebo. The authors explained this outcome of their study 
assuming that pregnancy had an adverse effect on the immune response of the cow 
(Guatteo et al., 2008). However, several studies reported that phase I vaccines failed to 
prevent shedding of C. burnetii in naturally infected prior to vaccination in cows, goats and 
sheep (Guatteo et al., 2008; Rousset et al., 2009b; Astobiza et al., 2010a), highlighting the 
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role of the vaccine in protecting uninfected but not in treating infected animals.  
Coxevac is registered for use in non pregnant cows to reduce excretion of C. burnetii. 
Under field conditions however it is frequently used out of label in pregnant cows to 
prevent shedding in a contaminated environment. In these terms the vaccine safety on 
pregnant animals it’s fundamental. Guatteo et al. (2008) observed in their study that the use 
of Coxevac in pregnant animals had no impact on pregnancy in cattle. 
Therefore vaccination cannot be considered as a classical treatment and a significant 
reduction of shedding in infected animals was not demonstrated. Also based on current 
diagnostic tests, it is not possible to serologically distinguish vaccinated and naturally-
infected animals. Nevertheless, vaccination on infected herds allowed to prevent the 
appearance of clinical signs and to significantly decrease the zootechnical losses to Q fever 
(Guatteo et al., 2008; EFSA, 2010; Guatteo et al., 2012).  
Antibiotic treatment 
Antibiotic treatment is used effectively in humans to reduce clinical symptoms associated 
with Q fever. Doxycycline, 100 mg twice daily for 14 days (Dumler et al., 2002) is 
recommended for acute illness. Antibiotic treatment lessens the time in which the patient 
has fever, (Gikas et al., 2001) and hastens recovery from pneumonia (Marrie, 2003). For 
endocarditis has been recommended a 18 months treatment of doxycycline (100 mg, twice 
daily) and hydroxychloroquine (200 mg, three times daily) (Maurin and Raoult, 1999). 
Chloroquine raises the pH in the phagolysosome increasing the efficacy of doxycycline 
((Raoult et al., 2005). 
In animals, antibiotic treatment did not show to be effective to prevent shedding of bacteria 
or limiting the duration of bacterial excretion in sheep (Astobiza et al., 2010b) and goats 
(Blain, 2006).  
In cattle antibiotic therapy is also frequently implemented in routine practice either at 
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drying off to prevent late abortion or at calving to prevent the shedding peak. Like in 
humans, because of its activity and its intracellular diffusion, tetracycline are the most used 
antibiotic (Taurel et al., 2014). The use of tetracyclines was associated with a prevention of 
vaginal shedding at calving in dairy cows, when injected once at drying off (Taurel et al., 
2012). 
The most used protocol consists of two injections of Oxytetracycline (20 mg/kg) during the 
last month of gestation (Arricau-Bovery and Rodolakis, 2005).  
In a study comparing the effectiveness of vaccination and/or antibiotics at different 
regimens to prevent and limit C. burnetii shedding at calving in dairy cows, the use of 
tetracycline was associated with a lower risk of being detected shedder at calving, but had 
no significant effect on the bacterial load shed (Taurel et al., 2012). On the basis of the 
update knowledge, the antibiotic treatment in domestic ruminants was considered not 
effective to substantially reduce either the level or the duration of bacterial shedding 
(EFSA, 2010).  
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1.8 TABLES AND FIGURES OF CHAPTER 1 
 
Table 1: Prevalence of C. burnetii (animal and herd level) in cattle in Europe and Turkey 
(EFSA, 2010). 
 
Country Yea
r of 
stud
No. tested % positive Testa Reference 
Cattle Herds Cattle Herd
s 
Albania 1999 552 
 
8.5 
 
ELISA Cekani et al., 2008 
 
1995-1997 311 
 
10.9 
 
ELISA Cekani et al., 2008 
Bulgaria 2002 3,006 
 
8.2 
 
CFT Martinov 2007a 
 
2003 3,714 
 
6.5 
 
CFT Martinov 2007a 
 
2004 120 
 
20.8* 
 
IFA Panaiotov et al., 
2009 
 
2004 3,188 
 
9.7 
 
CFT Martinov 2007a 
 
2005 3,026 
 
8.1 
 
CFT Martinov 2007a 
 
2006 2,932 
 
10.6 
 
CFT Martinov 2007a 
 
1989-2006 95,737 
 
5.4 
 
CFT Martinov 2007a 
 
1977-1988 20,086 
 
11.8 
 
CFT Martinov 2007a 
 
1950-1976 4,749 
 
19.8 
 
CFT Martinov 2007a 
Cyprus NA 75 
 
24.0 
 
IFA Psaroulaki et al., 
2006a Denmark 2008 
 
100 
 
59.0 ELISA- 
milk 
Agger et al., 2010 
 
2007 
 
742 
 
57 ELISA- 
milk 
Bodker and 
Christoffersen
, 2008 Italy 1998 544*** 21 13 nd IFA In Arricau-
Bouvery and 
  
155*** 6 2 nd IFA In Arricau-
Bouvery and 
  
486 26 20 nd IFA In Arricau-
Bouvery and 
 
NA 650 
 
44.9** 
 
ELISA Cabassi et al., 2006 
 
NA 600 
 
22.0 
 
ELISA Cabassi et al., 2006 
Germany 1998-2000 1,167 105 1.4 
to 
nd ELISA Sting et al., 2002 
 
1998 21,191 544 8 nd ELISA In Arricau-Bouvery 
2005 
 
1996-1997 826 38 14.3** 
0.6 
nd ELISA Sting et al., 2000 
 
1992-1993 500 NA 7.6 nd CFT Wittenbrink et al., 
1994 665 39 9.6 76.9 
383** 33 19.3 78.8 
612 Bulls 1 5.6 100 
 
1991 1,095 21 11.8 81 ELISA Rehacek et al., 1993 
 
1989-1990 3,500 155 13.3 57.4 ELISA Klemt and Krauss, 
1991 Netherlan
ds 
1987 1,160** 234 21 37 ELISA Muskens et al., 2007 
Spain 2006-2007 79 
 
35.4 
 
IFA Ruiz-Fons et al., 
2008 
 
2008-
2009? 
626 
 
6.7 
 
ELISA Ruiz-Fons et al., 
2010 
 
8-
2009? 
 
42 
 
42.9 ELISA Ruiz-Fons et al., 
2010 Turkey 6-2008 92 
 
16.3 
 
ELISA Ceylan et al., 2009 
 
2005 230 
 
9.6 
 
ELISA Seyitoglu et al., 
2005 
 
1998 416 48 6 nd 
 
In Arricau-
Bouvery and 
UK (NI) 2009 5,182 
 
6.2 
 
ELISA McCaughey et al., 
2010 
 
2009 
 
273 
 
48.4 ELISA McCaughey et al., 
2010 (a) Indirect Immunofluorescence assay (IFA), Enzyme Linked Immunosorbent assay (ELISA), Complement 
fixation test (CFT), Microagglutination test (MAT) 
* Investigation in relation to a human outbreak 
** Investigation in relation to clinical symptoms in the population (animals) 
*** The study was conducted to compare animals kept indoors (544) and outdoors (155) NA - not available; ML- 
most likely   
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Table 2: Prevalence of C. burnetii (animal and herd level) in sheep in Europe and Turkey 
(EFSA, 2010). 
 
SHEEP 
Country Year No. tested %positive  Test Reference 
Sheep Flocks Sheep Floc
ks Albania 1999 292 
 
12.3 
 
ELISA Cekani et al., 2008 
 
1995-1997 350 
 
8.9 
 
ELISA Cekani et al., 2008 
Bulgaria 2002 1,819 
 
12.7 
 
CFT Martinov 2007a 
 
2003 1,811 
 
8.3 
 
CFT Martinov 2007a 
 
2004 100 
 
21.0* 
 
IFA Panaiotov et al., 
2009 
 
2004 1,258 
 
14.1 
 
CFT Martinov 2007a 
 
2005 1,911 
 
15.2 
 
CFT Martinov 2007a 
 
2006 1,925 
 
8.4 
 
CFT Martinov 2007a 
 
1950-1976 17,088 
 
16.7 
 
CFT Martinov 2007a 
 
1977-1988 16,593 
 
18.8 
 
CFT Martinov 2007a 
 
1989-2006 99,189 
 
4.8 
 
CFT Martinov 2007a 
 
NA 153 
 
56.9** 
 
CFT Martinov. 2007b 
Croatia 2004 182 
 
11.0* 
 
CFT Medic et al., 2005 
Cyprus NA 481 
 
18.9 
 
IFA Psaroulaki et al., 
2006 Germany NA 
 
95 
 
2.7 
 
Runge and Ganter, 
2008 
 
1998 1,346 
 
1.3 
 
ELISA In Arricau-
Bouvery and 
 
1999 100 1 57 
 
ELISA In Arricau-
Bouvery and 
  
3,460 
 
8.7 
 
ELISA Sting et al., 2002 
Greece NA 554 
 
10.5 
 
IFA Pape et al., 2009a 
Italy 1999-2002 7,194 675 9/38 
 
ELISA In Arricau-
Bouvery and 
Netherlan
ds 
1987 3,603 
 
3.5 
 
ELISA In Muskens et al., 
2007 
 
2008 12,363 
 
2.4 
 
ELISA Van den 
Brom and P. 
Spain 1999-2003 
 
148 8.8** 
 
PCR Oporto et al., 2006 
 
1999-2003 
 
148 2.7** 
 
CFT Oporto et al., 2006 
 
1999-2003 38 
 
42.1** 
 
CFT Oporto et al., 2006 
 
2005 34 
 
67.6** 
 
ELISA Garcia-Perez et al., 
2009 
 
2005 1,011 
 
8.9 
 
ELISA Garcia-Perez et al., 
2009 
 
2005 
 
154 22.1 
 
ELISA Garcia-Perez et al., 
2009 
 
2007-2008 1,379 
 
11.7 
 
ELISA Ruiz-Fons et al., 
2010 
   
46 34 
 
ELISA Ruiz-Fons et al., 
2010 Turkey NA 465 
 
21.1** 
 
ELISA Karaca et al., 2009 
 
2001-2004 743 42 20 83 ELISA Kennerman et al., 
2010 
 
1998 411 
 
10.5 
 
IFA In Arricau-
Bouvery and 
Rodolakis 2005 UK (NI) NA 2009? 1,022 
 
12.3 
 
ELISA McCaughey et al., 
2010 
 
NA 2009? 
 
58 62.1 
 
ELISA McCaughey et al., 
2010 
        
(a) Indirect Immunofluorescence assay (IFA), Enzyme Linked Immunosorbent assay (ELISA), Complement 
fixation test (CFT), Microagglutination test (MAT) 
* Investigation in relation to a human outbreak 
** Investigation in relation to clinical symptoms in the population (animals) 
*** The study was conducted to compare animals kept indoors (544) and outdoors (155) NA - not available; 
ML- most likely 
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Table 3: Prevalence of C. burnetii (animal and herd level) in goats in Europe and Turkey 
(EFSA, 2010). 
 
GOATS 
Country Year No. tested % positive Test (a) Reference 
Goats Herds Goats Her
ds Albania 1999 260 
 
4.2 
 
ELISA Cekani et al., 2008 
 
1995-
1997 
443 
 
8.8 
 
ELISA Cekani et al., 2008 
Bulgaria 2002 677 
 
11.8 
 
CFT Martinov, 2007a 
 
2003 1,044 
 
7.4 
 
CFT Martinov, 2007a 
 
2004 50 
 
40.0* 
 
IFA Panaiotov et al., 
2009 
 
2004 1,016 
 
21.7 
 
CFT Martinov, 2007a 
 
2005 832 
 
11.1 
 
CFT Martinov, 2007a 
 
2006 359 
 
19.2 
 
CFT Martinov, 2007a 
 
1950-
1976 
1,417 
 
20.5 
 
CFT Martinov, 2007a 
 
7-
1988 
1,791 
 
10.8 
 
CFT Martinov, 2007a 
 
9-
2006 
54,175 
 
7.6 
 
CFT Martinov, 2007a 
Cyprus NA 417 
 
48.2 
 
IFA Psaroulaki et 
al.2006a France 2006 359 
 
36.0 
 
ELISA Dubuc-Forfait et 
al., 2009 
 
2006 
 
42 88.1 
 
ELISA Dubuc-Forfait et 
al., 2009 
 
2006 75 
 
65.3** 
 
ELISA Chaillon et al., 
2008 
 
2008 1,057 
 
32.0 
 
ELISA Dubuc-Forfait et 
al., 2009 
 
2008 42 
 
88.1 
 
ELISA Dubuc-Forfait et 
al., 2009 Germany 1998 278 
 
2.5 
 
ELISA In Arricau-
Bouvery and 
Greece NA 61 
 
6.6 
 
IFA Pape et al., 2009a 
Italy 1999-
2002 
2,155 104 13 47 ELISA In Arricau-
Bouvery and 
Rodolakis 2005 
Netherlan
ds 
1987 498 
 
1 goat 
 
ELISA Muskens et al., 
2007 
 
2008 3,409 
 
7.8 
 
ELISA Van den 
Brom and P. 
Poland NA, 
ML 
after 
98 
 
79.6** 
 
MAT Platt-Samoraj et 
al., 2005 
Spain 2007-
2008 
115 
 
8.7 
 
ELISA Ruiz-Fons et al., 
2010 
 
7-
2008 
 
11 
 
45.5 ELISA Ruiz-Fons et al., 
2010 Turkey 6-
2008 
92 
 
5.4 
 
ELISA Ceylan et al., 2009 
UK (NI) NA, 
ML 
54 
 
9.3 
 
ELISA McCaughey et al., 
2010 
 
NA, 
ML 
 
7 
 
42.9 ELISA McCaughey et al., 
2010 
(a) Indirect Immunofluorescence assay (IFA), Enzyme Linked Immunosorbent assay (ELISA), Complement 
fixation test (CFT), Microagglutination test (MAT) 
* Investigation in relation to a human outbreak 
** Investigation in relation to clinical symptoms in the population (animals) 
*** The study was conducted to compare animals kept indoors (544) and outdoors (155) NA - not available; ML- 
most likely 
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Table 4: Estimated prevalence of Coxiella burnetii infection in people, based on studies 
conducted in Bulgaria, France, Germany and the Netherlands, 1982–2010 (Georgiev, 
2013). 
  
Country Year of 
study 
Number 
tested 
Sample 
group 
% 
positive 
Test 
BG 1993–2000 14,353 RG 15.0 CFT, MIFT 
BG 1995–1997 224 BD 38.0 MAT, MIFT 
BG 2001–2004 5,207 RG 18.0 CFT, MIFT 
BG 2004 104 HO (PW) 7.7 IFA 
DE 2002 255 HO 22.0 NA 
FR 1982–1990 22,496 RG 23.0 NA 
FR 1988 924 BD 4.0 IFA 
FR 1995 790 BD 1.0 IFA 
FR 1995–1996 785 NA 5.0 IFA 
FR 1996 620 BD 3.0 IFA 
FR 1996 12,716 NA 0.2 IFA 
FR 1996 208 RG 71.0 IFA 
FR 2002–2003 376 RG (PW) 2.6 IFA 
FR 2002–2003 91 RG (CA) 5.5 IFA 
FR 2002–2003 578 HO 14.7 IFA 
NL 1982 222 RG 83.8 NA 
NL 1983 359 BD 24.0 NA 
NL 2006–2007 5,654 GP 2.4 ELISA, IFA 
NL 2007–2009 2,004 HO (PW) 9.1 IFA 
NL 2009 543 BD 12.2 ELISA, IFA 
BD: blood donors; BG: Bulgaria; CA: cardiac abnormalities; CFT: complement fixation test; DE: Germany; 
ELISA: enzyme-linked immunosorbent assay; FR: France; GP: general population; HO: humans in outbreak 
areas; IFA: indirect immunofluorescence assay; MAT: microagglutination test; MIFT: 
microimmunofluorescence test; NA: information not available or not specified; NL: Netherlands; PW: 
pregnant women; RG: risk group. 
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Figure 1: Number of notified human Q fever cases with a known first day of illness 
according to the week of onset of symptoms, from 1 January 2007 to 11 May 2010 (Roest 
et al., 2013).  
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Figure 2: pathogenesis of C. burnetii infection in ruminants: entry, dissemination and 
different outcome of the infection (modified from Barberio and Vicenzoni, 2013). 
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CHAPTER 2: Coxiella burnetii infection in dairy cows and 
goats: assessment of diagnostic methods, and evaluation of 
immune response in shedders 
 
2.1 MATERIALS AND METHODS 
 
2.1.1 Analytical methods 
Complement fixation test 
The CFT was performed in agreement with the OIE Manual of Diagnostic Tests and 
Vaccines for Terrestrial Animals (OIE, 2015). A commercial antigen was used, (Siemens 
Healthcare Diagnostic Products, Erlangen, Germany) that was a mixture of Nine Mile and 
Henzerling in phase II strains. Hamster complement was used (BioMérieux, Lyon, France) 
at a dilution corresponding at 2 unit (U). briefly the analytical procedure was the 
following: 
After predilution to 1:10 with Veronal buffer, cattle sera were inactivated for 30’ at 58° C 
and goats sera at 60° C. The antigen and the complement were then diluted in Veronal 
buffer. Then 25 µL of each sera were dispensed in microtitre plates for CFT test and 
anticomplementarity test (ACP). In CFT test plate sera were mixed with 25 µL of antigens 
and 25 µL of complement in each well; in ACP plate sera were mixed with 25 µL of 
Veronal buffer and 25 µL of complement. After agitation the plates were incubated at 
+5°C for 18 hours. Then 25 µL of hemolytic system, previously diluted and sensitized in 
waterbath at 37°C for 15’, were added to each well. After agitation plates were incubated 
at 37°C for 30’ centrifugated for 5’ at 2.000 r.p.m., and then reading was performed. 
The cut-off title was fixed at the titer of 1:10. 
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ELISA 
Sera and milk samples were analyzed with a commercial ELISA test, (LSIVET Ruminants 
milk/serum Q fever, Lissieu, France), according to manufacture instructions. The kit was 
an indirect ELISA with antigens in phase I and phase II isolated from domestic ruminants. 
Serum samples were prediluted 1:400, while milk samples were prediluted 1:20. The test 
results were calculated using the s/p ratio (ODsample-ODneg)/(ODpos-ODneg). Sera 
samples were classified as negatives if s/p ≤ 0.4, weak positives (+) if > 0.4 ≤1, medium 
positives (++) if > 1 ≤2, high positives (+++) if > 2 ≤3, very high positives (++++) if > 3. 
Milk samples (BTM) were classified as negatives if S/p ≤ 0.3, weak positives (+) if > 0.3 
≤1, medium positives (++) if > 1 ≤2, high positives (+++) if > 2. 
Molecular assays 
Molecular assays were performed using a real-time PCR (r-t PCR) commercial kit 
(ADIAVET® COX REALTIME, Adiagène Saint Brieuc, France). Pre-treatment and 
sample processing were performed according to the manufacturer’s instructions. The 
extraction of Coxiella DNA from different matrices was performed according to the 
manufacturer’s instructions (QIAamp DNA mini kit, Qiagen), as follows:  
- From milk: 400 µL of individual milk or BTM was transferred to a 1.5 mL microtube 
after vortexing.   
- From vaginal swabs: 1 ml of sterile water was added to the vaginal swab, the sample was 
vortexed for 30 s, and 200 µL of the supernatant was transferred to a 1.5 mL microtube.  
The instrument employed for r-t PCR was a Roche LightCycler 2.0 or an Applied 
Biosystems 7900 HT Fast Real- Time System. The diagnostic sensitivity of the r-t PCR 
analysis of the BTM samples was determined to be sufficient to detect 1 shedder cow in a 
group of 250 milking cows.  
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The amplification program is clarified in table 1 and was the same if Life Technologies or 
Roche instruments were used. 
Control samples with defined cycle threshold (ct) cycle values were used to verify the 
quality of the analysis performed. An internal positive control sample was coamplified for 
each sample tested to detect the presence of PCR reaction inhibitors in the sample. 
The individual milk samples that tested positive in the r-t PCR assay were divided into two 
classes depending on the ct cut-off value of 31. For this method, ct = 31 represents a 
concentration of 103 bacteria/ml (ADIAVET® COX REALTIME, validation data sheet, 
November 2010). Animals whose milk samples had ct values ≤ 31 were classified as high 
shedders, whereas animals with ct values > 31 were classified as low shedders. 
 
2.1.2 Study design 
2.1.2.1 Assessment of the efficacy of r-t PCR assays on BTM for the detection of infected 
dairy herds and flocks 
The sensitivity and specificity of a single r-t PCR test on BTM were evaluated using a 
control-case study in dairy cattle and goat farms. The first step was the identification of 
infected and negative farms, in which a sample of BTM was taken for a r-t PCR test to 
detect C. burnetii DNA. 
Dairy cattle 
In dairy cattle the infected herds, according to the literature (Sidi-Boumedine et al, 2010; 
Guatteo et. al., 2011), were defined as farms with: 
• clinical symptoms of Q fever like abortions or infertility, 
• at least one positive r-t PCR result confirming the presence of the agent of Q fever on 
specimens from affected animals, 
• a prevalence ≥ 20%. 
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Negatives farms were defined as farms with: 
• a regular surveillance and diagnosis of abortions, 
• all the r-t PCR test on abortions or vaginal swabs negative for C. burnetii, 
a prevalence < 20%. 
The herds enrolled in the study were farms that undergo to a regular surveillance and 
diagnosis of abortions in the monitoring plan of Regione Veneto for bovine abortions. All 
Aborted foetuses accompanied by the dam’s blood sample were delivered to the diagnostic 
laboratory of Istituto Zooprofilattico delle Venezie (IZSVe) and submitted to a panel of 
laboratory tests. The sera were tested for antibodies against Brucella, Neospora, IBR, 
Leptospira, BVD, Q fever, Chlamydophila, and the foetuses were tested for the detection 
of the following agents: bacteria, Neospora caninum, BVD virus, Chlamydophila, and C. 
burnetii. 
All the farms with a C. burnetii r-t PCR positive abortion, were reached by means of their 
veterinary practitioners, and sampled. Among the farms with negative r-t PCR and 
serology were selected 73 herds having the following features: 
 perform a regular surveillance and diagnosis of abortions including laboratory 
diagnosis performed at the IZSVe, 
 be included in the dairy herd improvement (DHI) control system performed by the 
Italian Breeders Association (AIA). 
These negative herds were then tested with a prescreening test to detect the presence of 
antibodies against C. burnetii in a BTM sample collected from the employs of breeders 
association during the DHI controls. The samples were frozen at -20° C after the 
collection, shipped to the IZSVe laboratory and tested with ELISA for the detection of 
anti-C. burnetii antibodies. Only farms with ELISA negative result were included in the 
study. 
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In all the herds, positive and negative, included in the trial, to assess the prevalence of C. 
burnetii infection, 13 cows were randomly selected and a blood sample (nearly 10 ml) was 
taken from the tail vein of each cow using a vacuum tube (Vacutainer, Becton Dickinson, 
Franklin Lakes, NJ, USA). The number of cows to be tested were 13 because it allows to 
detect with a confidence level of 95% at least 1 positive cow if the prevalence is ≥ 20%.  
The samples were stored in a bag refrigerated with eutectic plates, transported to the 
laboratory, centrifugated at 3.000 r.p.m. for 10’, and the sera were stored at -20° C. All the 
samples were tested with ELISA and CFT. 
At the same time a 60 ml of milk sample were taken from the bulk tank, that was 
previously mixed for 5’ using the automatic tank stirrer. The milk was stored in a 
refrigerated bag with eutectic plates, transported to the laboratory, split in 2 tubes and 
stored at -20° C. One tube was used for r-t PCR test to detect C. burnetii DNA and the 
other kept frozen in case the analysis had to be repeated.  
Dairy goats 
In dairy goats the infected flocks, according to the literature (Sidi-Boumedine et al, 2010; 
Guatteo et. al., 2011), were defined as farms with: 
• clinical symptoms of Q fever like abortions or infertility, 
• at least one positive r-t PCR result confirming the presence of the agent of Q fever on 
specimens from affected animals, 
• a prevalence ≥ 15%. 
Negatives flocks were defined as farms with: 
• a regular surveillance and diagnosis of abortions; 
• all the r-t PCR test on abortions or vaginal swabs negative for C. burnetii, 
• a prevalence < 15%. 
The Flocks enrolled in the study (29) were selected in the province of Trento, Vicenza and 
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Belluno, among dairy flocks with at least 20 goats. All the flocks enrolled in the study 
were regularly visited every 15 days from November to April: all the abortions were 
registered, vaginal swabs were taken from goats that aborted and also from animals with 
regular kidding, to perform C. burnetii r-t PCR. All the flocks enrolled were sampled to 
evaluate the seroprevalence, and BTM for r-t PCR was taken.  
Vaginal swabs (Becton Dickinson, Franklin Lakes, NJ, USA) were taken from the vagina 
after cleaning and disinfection of the vulva with a disinfecting solution (5% Virkon S™, 
Dupont USA). After sampling the swabs were placed in sterile tube, stored in a refrigerated 
bag, transported to the laboratory, and stored at -20° C. Afterward they were tested with r-t 
PCR test to detect C. burnetii DNA. 
In all the flocks included in the trial, to assess the prevalence of C. burnetii infection, 18 
goats were randomly selected and a blood sample (nearly 10 ml) was taken from the 
jugular vein of each goat using a vacuum tube (Vacutainer, Becton Dickinson, Franklin 
Lakes, NJ, USA). The number of goats to be tested were 18 because it allows to detect 
with a confidence level of 95% at least 1 positive cow if the prevalence is ≥ 15%.  
The samples were stored in a bag refrigerated with eutectic plates, transported to the 
laboratory, centrifugated at 3.000 r.p.m. for 10’ and the sera were stored at -20° C. All the 
samples were tested with ELISA and CFT. 
At the same time a 60 ml of milk sample were taken from the bulk tank, that was 
previously mixed for 5’ using the automatic tank stirrer. The milk was stored in a 
refrigerated bag with eutectic plates, transported to the laboratory, split in 2 tubes and 
stored at -20° C. One tube was used for r-t PCR test to detect C. burnetii DNA and the 
other kept frozen in case the analysis had to be repeated.  
 
74 
 
2.1.2.2 Evaluation of the dynamics of the antibodies response, and the C. burnetii excretion 
in infected animals  
Dairy cattle 
Among the infected dairy farms involved in the study were selected 4 herds with: 
 at least 1 abortion and the BTM positive to r-t PCR for C. burnetii DNA,  
 an average number of lactating cows > 100 and < 400,  
 the approval of the farmer to participate at the study and his commitment to don't 
interrupt the trial before the end of the study. 
In each of the enrolled herds was performed a first screening collecting from each of the 
lactating cows a sample of blood from the tail vein using a vacuum tube (Vacutainer, 
Becton Dickinson, Franklin Lakes, NJ, USA), and a sample of milk taken from the 
foremilk of each quarter, prior of the attachment of the milking group. Milk samples were 
collected according to the National Mastitis Council guideline for milk sample and 
handling (National Mastitis Council, 1999).  
The samples were stored in a bag refrigerated with eutectic plates and transported to the 
laboratory. At the laboratory blood samples were centrifugated at 3.000 r.p.m. for 10’,the 
sera were stored at -20° C, and afterward were tested with ELISA and CFT for the 
detection of antibodies against C. burnetii. Milk samples were split in 2 tubes, stored at -
20° C, and afterward 1 tube was used for r-t PCR test to detect C. burnetii DNA, and the 
other kept frozen in case the analysis had to be repeated. 
According to the test results, were established 4 groups of nearly 10 cows to be sampled 3 
times every 2 months. The cows were sorted among the groups as follow: 
 group 1: cattle ELISA negative and PCR negative (ELISA-PCR-); 
 group 2: cattle ELISA negative and PCR positive (ELISA-PCR+); 
 group 3: cattle ELISA positive and PCR negative (ELISA+PCR-); 
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 group 4: cattle ELISA positive and PCR positive (ELISA+PCR+). 
From these cows at each control was taken a sample of blood, milk and feces and tested, 
serum with ELISA and CFT for antibodies detection, milk and feces with r-t PCR for C. 
burnetii DNA detection. 
the 4 groups of cows were created considering also these elements: 
 days in milk: when possible cows at the beginning of lactation were chosen, 
 CFT results: when possible in the group ELISA+ PCR+ and ELISA+ PCR- where 
introduced cows that were also CFT positive. 
Dairy goats 
Among the infected flocks enrolled in the r-t PCR assessment only 2 farmers approved the 
participation to the study, so a 3rd infected flock was included in the study, despite the 
number of lactating goats was only 12. 
In each of the enrolled flocks was performed a first screening collecting from each of the 
lactating goats a sample of blood from the jugular vein using a vacuum tube (Vacutainer, 
Becton Dickinson, Franklin Lakes, NJ, USA), and a sample of milk taken from the 
foremilk of each halves, prior of the attachment of the milking group. Milk samples were 
collected according to the National Mastitis Council guideline for milk sample and 
handling (National Mastitis Council, 1999).  
The samples were stored in a bag refrigerated with eutectic plates and transported to the 
laboratory. At the laboratory blood samples were centrifugated at 3.000 r.p.m. for 10’,the 
sera were stored at -20° C and afterward were tested with ELISA and CFT for the detection 
of antibodies against C. burnetii. Milk samples were split in 2 tubes, stored at -20° C, and 
afterward 1 tube was used for r-t PCR test to detect C. burnetii DNA and the other kept 
frozen in case the analysis had to be repeated. 
According to the test results, were established 3 groups to be sampled 3 times every 2 
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months. The goats were sorted among the groups as follow: 
 group 1: goats ELISA negative and PCR negative (ELISA-PCR-); 
 group 2: goats ELISA positive and PCR negative (ELISA+PCR-); 
 group 3: goats ELISA positive and PCR positive (ELISA+PCR+). 
From these goats at each control was taken a sample of blood, milk and feces and tested, 
serum with ELISA and CFT for antibodies detection, milk and feces with r-t PCR for C. 
burnetii DNA detection. 
 
2.1.3 Herds and flocks features 
Dairy cattle 
 Herd 1: the total number of cattle was 214, the breed Italian Holstein, on average the 
number of milked cow in the year was 107. The housing system was freestall barns and 
the cows were milked in a herringbone parlour. Abortion and metritis cases were 
reported < 5%, but poor fertility rate was one of the main problem of the farm. 
 Herd 2: the total number of cattle was 215, the breed Brown, on average the number of 
milked cow in the year was 107. The housing system was freestall barns and the cows 
were milked in a tandem parlour. Several late abortions with detection of C. burnetii 
occurred in the farm in the last 16 months, and poor fertility rate was one of the main 
problem of the farm. 
 Herd 3: the total number of cattle was 239, the breed Italian Holstein, on average the 
number of milked cow in the year was 100. The housing system was freestall barns and 
the cows were milked in a herringbone parlour. Abortion and metritis cases were 
reported < 5%, but poor fertility rate was one of the main problem of the farm. 
 Herd 4: the total number of cattle was 606, the breed Italian Holstein, on average the 
number of milked cow in the year was 294. The housing system was freestall barns and 
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the cows were milked in a herringbone parlour. Several late abortions with detection of 
C. burnetii occurred in the farm in the last 6 months, and poor fertility rate was one of 
the main problem of the farm. 
Dairy goats 
 Flock 1: the average number of milked goats was 80, the breed were Alpine and 
Saanen. The goats were housed in a concrete building with pens separated according to 
the functional state of the animals: lactating, dryed-off, young goats. Bedding material 
used was straw and each pen was in communication with an external paddock. Goats 
were milked in a parallel milking parlour. Milk was in part sold to a dairy company and 
in part used in the farm for cheese production, that was sold directly to the consumers. 
Abortion cases were reported < 5%. 
 Flock 2: the number of milked goats was 12, the breed were Alpine and Saanen. The 
goats were housed in a concrete building separated in 2 pens, 1 for lactation goats, and 
the other for the young and dryed-off goats. Bedding material used was straw and each 
pen was in communication with an external paddock. Goats were milked in a small 
parallel milking parlour (3 places). In the summer the goats were sent to a mountain 
farm where they were kept grazing with other goats from other farms. Also in the 
summer milking was performed in a parallel milking parlour. During the winter milk 
was sold to a dairy company, in the summer was used in the mountain farm for cheese 
production that was sold directly to the consumers. Several abortion cases were 
reported in the last year (> 15%). 
 Flock 3: the average number of milked goats was 180, the breed were Alpine and 
Saanen. The goats were housed in a concrete building with pens separated according to 
the functional state of the animals: lactating, dryed-off, young goats. Bedding material 
used was straw and each pen was in communication with an external paddock. Goats 
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were milked in a parallel milking parlour. All the milk was used to produce cheese in a 
authorized dairy plant annexed to the farm, and the product was sold to shops or 
directly to the consumers. Abortion cases were reported < 5%. 
 
2.1.4 Statistical analysis 
The evaluation of the performance of r-t PCR in BTM was done by estimation of 
sensitivity and specificity according to the definition of Martin et al., (1987).  
The statistical association between the serological status of the cows in infected herds and 
the occurrence of C. burnetii shedding in milk was evaluated using the logistic regression 
and the statistic of Wald assuming alfa = 0.05: only p value < 0.05 were considered 
statistically significant. The level of association was estimated by mean of the Odds ratio 
(OR). The OR estimates the different probability of a serological positive cow to be 
shedders of C. burnetii in milk compared to a serological negative cow. The OR was 
estimated comparing the results of r-t PCR test in milk of each cow with the result of CFT 
test and ELISA test. Furthermore was estimated the OR of the comparison between results 
of r-t PCR test in milk and the serological status only of the cow with a high positive 
response to the ELISA test. For this purpose a different ELISA cut-off was used (s/p >2). 
each OR was estimated with the confidence level (CI) at 95%. The estimation of the 
agreement between ELISA and CFT was performed using the Cohen's Kappa coefficient. 
All the statistics was performed by mean of SPSS Statistics vers. 21 (IBM). 
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2.2 RESULTS 
 
2.2.1 Assessment of the efficacy of a r-t PCR assay on BTM for the detection of 
infected dairy herds 
Dairy cattle 
C burnetii was detected in fetuses or placenta of 17 dairy cattle farms that submitted their 
samples for the diagnosis of abortion to the IZSVe laboratories,. The great majority of 
these herds (16) had a within-herd seroprevalence for C. burnetii antibodies ≥ 20% (table 
2). The r-t PCR on BTM gave a positive result in 9 herds among 17. Of these BTM 
positive herds, 8 had a within-herd seroprevalence ≥ 20%, and only 1 herd had a 
seroprevalence < 20%. To check if this peculiar result was due to a recent infection, all the 
cows of the herd were tested for C. burnetii serology using ELISA after 2 months and also 
the BTM sample was repeated. BTM was confirmed as positive to r-t PCR also in the 
second sample and out of 52 sampled cows only 5 (9,6%) had a positive result to ELISA 
test.  
The herds classified as infected, according to the definition stated in the study design, were 
16: only in 8 (50%) of these herds the BTM was found positive to r-t PCR. 
If the within-herd prevalence was assessed using the CFT instead of ELISA, the herds 
classified as infected turned out to be 12 instead of 16. In 8 (67%) of these herds the BTM 
was found positive to r-t PCR, while in other 4 herds the BTM was negative to r-t PCR 
(table 3). 
To find out farms uninfected from C. burnetii, 73 herds were selected among these with a 
surveillance control plan on abortions, based on routine laboratory diagnosis of abortions. 
All the samples submitted by these herds were negative both at r-t PCR and serological test 
of the cows that aborted. Nevertheless in 51 (70%) of these herds, BTM was found positive 
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for antibodies against C. burnetii and they were removed from the study. 
Therefore only 22 herds were sampled: 12 (55%) showed a within herd prevalence ≥ 20% 
and 10 (45%) < 20%. The r-t PCR detected C. burnetii DNA only in the BTM of 6 herds 
(table 2): all these herds had a within-herd prevalence ≥ 20%. In these 22 herds the ELISA 
test for antibodies detection on BTM was repeated on the new samples taken for r-t PCR. 
Out of the 22 BTM samples tested, 5 turned positive to the ELISA test and 4 of them 
belonged to farms with a within-herd prevalence ≥ 20%. Out of the 6 samples positive to 
the r-t PCR, 3 were also positive for antibodies against C. burnetii and 2 remained 
negative. 
The herds classified as uninfected, according to the definition stated in the study design, 
were 10: of these herds none had a positive r-t PCR result in the BTM sample. 
If the within-herd prevalence was assessed using the CFT instead of ELISA, the herds 
classified as uninfected were 17 instead of 10. Of these herds in 2 (12%) the BTM was 
found positive to r-t PCR, while in other 15 herds (88%) the BTM was negative to r-t PCR 
(table 3). 
The number of infected herds was 16 and the number of uninfected herds was 10, while 13 
herds could not be classified as infected or uninfected due to the lack of one or more 
features (within-herd prevalence or presence/absence of C. burnetii abortions). The 
sensitivity and specificity of BTM r-t PCR, calculated using these data, were respectively 
equal to 0.5 and 1 (table 4).  
If the within-herd prevalence was assessed using the CFT instead of ELISA, the herds 
classified as infected were 12 and those classified as uninfected 17: the sensitivity and 
specificity of BTM r-t PCR, were respectively equal to 0.7 and 0.9 (table 5). 
The ELISA test used for the detection of seropositive cows in the herds has different levels 
of positive s/p value cut-off, that allows to distinguish among positive animals the 
81 
 
following groups: weak positives (+) if > 0,4 ≤1, medium positives (++) if > 1 ≤2, high 
positives (+++) if > 2 ≤3, very high positives (++++) if > 3. 
Taking into account the possibility that the majority of false positive results in the ELISA 
test are included in the group of weak positives (Guatteo, 2007), we estimated the within-
herd seroprevalence, assuming as positive only the samples with a s/p value > 1, excluding 
all the weak positive samples. Using this cut-off  to assess of the within-herd prevalence, 
no difference was found in the classification of the infected herds: all the 16 farms 
previously classified as infected, had at least 1 cow with a s/p value > 1 (table 6). 
In the classification of uninfected herds, the use of this cut-off allowed to increase the 
number of herds included in the definition of uninfected herds from 10 to 14. Indeed in 4 
of the herds with negative abortions for C. burnetii, the within-herd seroprevalence change 
from ≥ 20% to < 20%, as only 1 weak positive sera was found in these herds. All these 4 
farms were negative to r-t PCR in the BTM sample, therefore the sensitivity and specificity 
of a single test on BTM by mean of the r-t PCR, were exactly the same as those obtained 
with the previous ELISA cut-off, respectively 0,5 and 1 (table 7). 
Dairy goats 
The dairy goat flocks followed during the study were located mainly in the province of 
Trento (18), but there were also 8 flocks in the province of Vicenza and 3 in the province 
of Belluno. In the farms kidding were scattered throughout the observation time, 
(November – April), but the great majority occurred between December and February. 
Out of the 29 flocks sampled in the study, 15 (51%) had goats shedding C. burnetii from 
vagina mucus after abortions and also after normal parturition (table 2). In all flocks C. 
burnetii DNA was detected in at least 2 or more goats after kidding. No abortion storms 
occurred during the trial, but only single cases of abortions, which occurs more often in  
the enzootic form of the disease. Most flocks with vaginal swabs positive for C. burnetii 
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were located in the province of Trento (13), and only 2 in the province of Vicenza. 
Among these flocks only 9 (60%) had a within-flock seroprevalence for C. burnetii 
antibodies ≥ 15% (table 8). The r-t PCR on BTM gave a positive result in 8 flocks out of 
15. Of these BTM positive flocks, 7 had a within-flock seroprevalence ≥ 15%, and only 1 
flock had a seroprevalence < 15%. 
The flocks classified as infected, according to the definition stated in the study design, 
were 9: only in 8 (89%) of these flocks the BTM was found positive to r-t PCR. 
If the within-flock prevalence was assessed using the CFT instead of ELISA, the flocks 
classified as infected were only 2 instead of 9 and only in 1 flock the BTM was found 
positive to r-t PCR (table 9). 
The flocks in which all the vaginal swabs collected tested negative for C. burnetii DNA, 
detection were 14 (49%). All these flocks had a within-flock seroprevalence < 15% and the 
BTM negative C. burnetii (table 8), thus all the 14 flocks were classified as uninfected. 
The same result was obtained if the within-flock seroprevalence was assessed using the 
CFT instead of ELISA. Therefore, the number of infected flocks was 9 and the number of 
uninfected flocks was 14, while 6 flocks could not be classified as infected due to the low 
within-herd seroprevalence. The sensitivity and specificity of the BTM r-t PCR, calculated 
using these data, were respectively equal to 0.8 and 1 (table 10). 
If the within-flock prevalence was assessed using the CFT instead of ELISA, the flocks 
classified as uninfected were 13 instead of 14, because in 1 flock a high number of CFT 
positives and ELISA negatives sera (14 among 18) was detected. 
As in dairy cattle, the within-flock seroprevalence was then estimated, assuming as 
positive only the samples with a s/p value > 1 and excluding all the weak positive samples. 
Using this cut-off for the assessment of the within-flock seroprevalence, the flock 
classified as infected were 7 instead of 9. The BTM r-t PCR was positive in all these 
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flocks. No difference of course was found in the classification of the uninfected herds, 
because all the sera tested were negative to the ELISA (table 11). Differently from what 
happened in dairy cows, the use of this cut-off reduced the number of flocks included in 
the definition of infected from 9 to 7. The sensitivity of BTM r-t PCR moved from 0.8 to 1, 
while the sensitivity remained unchanged equal to 1 (table 12). 
 
2.2.2 Evaluation of the dynamics of the antibodies response and the C. burnetii 
excretion in infected animals 
Dairy cattle 
In the first sampling performed on the 4 infected dairy herds, 608 lactating cows were 
sampled. Table 13 and 14 show the results of the analysis performed on milk and blood 
samples, collected from each cow. The number of cows shedding C. burnetii in milk was 
48 (7.9%), the number of seropositive cows to ELISA test was 181 (29.8%) and the 
number of seropositive cows to CFT test was 65 (10.7%). 
The ELISA test allows to distinguish among positive animals the high positive ones: this 
was the reason to calculate also the number and percentage of cows with an s/p cut-off > 2, 
that include only high and very high positive animals. The number of high positive cows 
was 85 (14%).  
The percentage of positive cows to r-t PCR among herds ranged from 4.4% to 13.1%: if we 
consider the number of positive cows of each herd, this value was very similar and ranged 
from 10 to 14. The percentage of seropositive cows to the ELISA test was more variable 
among herds, ranging from 21.5% to 48%, while the percentage of  CFT seropositive cows 
ranged from 8% to 15.9%. 
Animals  with r-t PCT positive milk samples were sorted in 2 groups according to their ct: 
those with ct values ≤ 31 were classified as high shedders of C. burnetii, the others as low 
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shedders. The number of high shedders was 12 (table 14), equal to 2% of the total number 
of animals and 25% of the PCR positive cows. It should be highlighted that all 12 high 
shedder cows were classified as high positive to ELISA test, while only 5 of these cows 
were positive to CFT test. 
After the first sampling, according to the results of ELISA and r-t PCR, the cows were 
grouped as follows and sampled 3 other times every 2 months: 
 group 1: 49 cows ELISA negative and PCR negative (ELISA-PCR-); 
 group 2: 14 cows ELISA negative and PCR positive (ELISA-PCR+); 
 group 3: 43 cows ELISA positive and PCR negative (ELISA+PCR-); 
 group 4: 34 cows ELISA positive and PCR positive (ELISA+PCR+). 
Table 15  shows the size of each group at each time of sampling: it is interesting to note 
that among the  r-t PCR positive cows, 14 were seronegative to ELISA test. Furthermore 
all these cows were also negative to CFT. During the study, 31 cows were culled before the 
last sampling: these cows have been culled because of health problems, mainly infertility, 
metabolic disease and lameness. It is very difficult to evaluate whether the persistence of 
the C. burnetii infection could be related to the culling of these animal, due to the high 
replacement rate of intensive dairy farms in the Veneto area, but the group from which the 
majority of animals were culled, was the ELISA+PCR+, as showed in table 16.  
In group 1, ELISA-PCR-, 3 cows belonging to different herds, at 2nd, 3rd and 4thsampling, 
changed their status and became shedders of C. burnetii in milk only in 1 single sampling, 
but did not develop an antibodies response. In the same group, 7 cows became slightly 
seropositive but at the following sampling, they turned back to seronegative status, thus it 
is  very likely that this variation was due to an aspecific response to the ELISA test  rather 
than to a seroconversion. 
The evolution of group 2, the cows ELISA-PCR+, was quite interesting. The majority of 
85 
 
these cows, 12 out of 14, stopped the shedding of C. burnetii in milk after the first 
sampling and from the 3rd one, all cows tested negative at the r-t PCR on milk. Despite this, 
it was expected that over the time these cows would produce antibodies against C. burnetii 
due to the presence of the infection, whereas they remained seronegative for all the study 
time except for 1 cow, which showed a transitory seroconversion at the 3rd sampling.  
In group 3, the cows ELISA+PCR-, 14 cows became shedders in milk at the 2nd sampling 
and 4 of these cows remained positive to r-t PCR in milk for all the time of the study. 
Other 2 cows became seronegative at the 3rd sampling, but turned again seropositive at the 
4th sampling, and other 2 cows became seronegative at the last sampling. 
In group 4, cows ELISA+PCR+, all cows remained seropositive throughout the study time, 
even if it should be considered that 50% of the cows of this group were culled before the 
end of the trial. Regarding the shedding of C. burnetii by these cows, 24 of them were 
found positive at least at 2 consecutive samplings and 9 cows were positive at 3 
consecutive samplings. 
The DNA of C. burnetii was detected in the feces of 9 cows only . All 9 cows had only 1 
single positive sample without persistence of shedding during the time of the study (table 
17). Among these 9 positive samples, 8 had a high ct, ranging from 37.12 and 38.86 with 
cows belonging all to the same herd, while only 1 sample from a different herd, had a 
lower ct equal to 29.30 Of these 9 cows, 5 were ELISA-PCR -, 1 was ELISA-PCR+, 1 was 
ELISA+PCR-, and 2 ELISA + PCR +. The cow with the lower ct was ELISA–PCR-. Of 
these cows, 3 tested positive during dry-off and the remaining 6 had a negative PCR test in 
milk. 
The results of the serological and molecular test performed at the first sampling were 
compared to evaluate the relation between the serological status of the cows in infected 
herds and the occurrence of C. burnetii shedding in milk. Tables 18 and 19 show the output 
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data of this comparison: the percentage of agreement between r-t PCR in milk and CFT 
was only 35.4% for positive samples, while for negative samples it was 91.4%. The 
percentage of seronegative cows (at the CFT test) shedding C. burnetii in milk, was 64.6%. 
The OR of the comparison was 5.8 (table 20), in other words the probability that a CFT 
seropositive cow would be a C. burnetii shedder in milk is 5.8 time greater than for a CFT 
seronegative cow. The percentage of agreement between r-t PCR in milk and ELISA was 
70.8% for positive samples, while for negative samples it was 73.8%. The percentage of 
seronegative cows (at the ELISA test) shedding C. burnetii in milk, was 29.2%. The OR of 
the comparison was 6.8 (table 20). 
The agreement between FDC and ELISA, measured with Cohen's K was 0.42, a level of 
agreement defined as fair.  
In a study by Guatteo et al. (2007) it was described that cows with a high serological titer 
(S/p>2), had a greater probability of being persistent shedders and the authors proposed 
this ELISA cut-off, to screen cows in order to detect persistent shedders. For this reason 
we checked whether using this cut-off value it was possible to increase the probability to 
detect cows shedding C. burnetii in milk.  
The output data of this comparison are displayed in table 21: the percentage of agreement 
between r-t PCR in milk and ELISA decreased from to 70.8% to 54.2% for positive 
samples, while for negative samples it increased from 73.8% to 89.5%. The number of 
ELISA seropositive cows with PCR negative results decreased from 26.3% to 10.5%, but 
the percentage of seronegative cows shedding C. burnetii in milk, rose from 14 % to 22%. 
The OR increased from 6.8 to 10.03 (table 20). 
A better evaluation of the use of serology for herds screening to identify suspect persistent 
shedders of C. burnetii is possible considering all 4 samples taken during the study, from 
cows with PCR positive milk samples. Therefore the cows with at least 2 positive milk r-t 
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PCR tests were identified as persistent shedders and a new comparison was performed to 
evaluate the association between the serological status of the cows and the persistent 
shedding of C. burnetii in milk.  
Table 22 shows the output data of this comparison: the percentage of ELISA seropositive 
cows with PCR negative was 27.2% and only 2 (8.3%) out of 24 persistent shedder cows 
were seronegative at the ELISA test. The OR was extremely high, 29.4 (table 20). If the 
cut-off of ELISA test was raised up to > 2, including only the high seropositive cows, the 
percentage of ELISA seropositive cows with PCR negative was 11.6% and the number of 
persistent seronegative shedder cows was 7 (29.2%). The OR was 18.4 (table 20). 
Dairy goats 
The results of serological and molecular tests performed are displayed in table 22. At first 
sampling in the 3 infected flocks 257 lactating goats were sampled. Graph 1 shows the 
results of the analysis performed on milk and blood samples collected from each goat. The 
number of goats sampled from each flock was very different, ranging from 12 to 171, due 
to the different size of the flocks. The goats shedding C. burnetii in milk were 59, the 23% 
of the sampled animals, the ELISA seropositive goats were 177 (69%) and the CFT 
seropositive ones were 11 (4%). The percentage of C. burnetii shedders in milk was very 
different among the 3 flocks, ranging from 100% of goats in flock 2 to 1% in flock 3, while 
the percentage of seropositive goats was more uniform and above 60% in all 3 flocks, 
ranging from 65% to 83%. In flocks 1 and 2 none of the sampled goats was positive to 
CFT test, in flock 3 only 6% of animals exhibited the presence of complement fixing 
antibodies.  
After the first sampling, according to the results of ELISA and r-t PCR, the goats were 
grouped as follows and sampled 3 other times every 2 months: 
 group 1: 15 goats ELISA negative and PCR negative (ELISA-PCR-), 
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 group 2: 17 goats ELISA positive and PCR negative (ELISA+PCR-), 
 group 3: 22 goats ELISA positive and PCR positive (ELISA+PCR+). 
Differently from cows, only 1 ELISA-PCR+ goat was found (flock 2), so it was impossible 
to create a group with a single animal, but even this goat was sampled 3 times during the 
trial. Moreover while in flock 1 and 2 animals originated from all groups, in flock 2, where 
all goats were PCR positive, the only present group was ELISA+PCR+. 
At  2ndsampling in flock 1 and 2 the number of goats shedding C. burnetii in milk had 
sharply decreased and only 1 positive goat was found in either flocks, while in flock 3 the 
2 milk shedders were still found positive at r-t PCR. At this sampling in flock 1 the feces 
of 15 goats were found positive at r-t PCR. Of these goats 7 belonged to the ELISA+ 
PCR+ group, 5 to the ELISA+ PCR- group and 3 to the ELISA-PCR- group. The only goat 
that was still shedding C. burnetii in milk was also shedding in feces. All the ct of the r-t 
PCR positive feces were > 35, therefore the bacterial load of C. burnetii excreted with 
feces was very low. Further 1 goat with positive r-t PCR in feces was found in flock 2: this 
goat was in the group ELISA+PCR+ but at this sampling her milk was negative at the r-t 
PCR.  
At 3rd sampling all milk samples in flocks 1 and 2 were negative, while in flock 3 the same 
2 goats were still shedding C. burnetii in milk. In flock 1, out of the 15 goats shedding C. 
burnetii in feces at 2nd sampling, 9 were still shedding it in feces and 4 new goats were 
positive in feces. In flock 2 a new goat was found positive at r-t PCR in feces.  
At 4th sampling in flock 1, 2 goats belonging to the ELISA+PCR- group were found 
positive at r-t PCR on milk, in flock 2 no milk positive goats were found and in flock 3 
only 1 goat was still positive. In flock 1 5 goats were still shedding C. burnetii in feces, 2 
belonging to the ELISA+PCR group + and 3 to the ELISA+PCR- group.  
The pattern of C. burnetii excretion in feces was very different between flock 1 and the 
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other 2 flocks. In flocks 2 and 3 this way of shedding was only sporadic and limited to 
respectively 2 and 1 goat, while in flock 1 several goats started to shed C. burnetii in feces. 
Out of 15 fecal shedders found at 2nd sampling, 3 remained positive for 3 consecutive 
samplings, 6 for 2 and 10 at only 1 sampling. Among the goats shedding C. burnetii in 
feces for 2 or 3 samplings, some belonged to the ELISA+ PCR+ and other to the ELISA+ 
PCR- groups: no seronegative goats were found shedding in feces, as seen in flock 3. 
The great majority of seropositive goats remained in this status until the end of the study, 
only 3 goats out of 39 (7%) were negative at ELISA test at last sampling, while 3 goats out 
of 15 (20%) became positive at ELISA test. The evaluation of the serological status of the 
goats with CFT was very difficult: in flocks 1 and 2 at 1st sampling no positive animal 
were found, at the 2nd one a high proportion of goats, respectively 35% and 25%, were 
found positive, but at last sampling all goats where negative again. In flock 3 at 1st 
sampling 6% of goats were positive, at the 2nd all the goats were negative, at the 3rd 90% of 
goats were positive, at 4th sampling 25% of goats were positive. These remarkable 
variations in a relative short time were unpredictable and not associated with C. burnetii 
shedding. 
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2.3 DISCUSSION 
 
2.3.1 Assessment of the efficacy of r-t PCR assays on BTM for the detection of 
infected dairy herds and flocks 
The criteria for the definition of C. burnetii infection are much easier to apply to a single 
animal than to a herd or flock. For this reason the definition of infected or uninfected herd 
or flock used in this study was is very precise and has considered all elements that 
demonstrated the active circulation of the etiological agent in herds or flocks, taking in 
account other studies published on this subject (Sidi-Boumedine et al, 2010; Guatteo et. al., 
2011). 
The results of the test performed in dairy cows highlighted that when C. burnetii abortions 
occurred in a herd the within-herd seroprevalence is greater than > 20%, even  if a less 
sensitive test, as CFT, is used. When ELISA test was used, it was possible to evaluate the 
results with a cut-off that did not include the weak positive samples, without any change in 
the number of infected detected herds . These findings confirmed that in infected herds the 
circulation of C. burnetii usually triggered a strong antibodies response in cows. The 
situation found in 1 single herd remained unexplained, where, despite the presence of 
abortions and PCR positive BTM, most of cows tested seronegative even several months 
later: the only possible explanation is the presence of few seronegative cows shedding C. 
burnetii in milk, phenomenon already described in cows infected by C. burnetii 
(Rodolakis, 2006). 
The results obtained with r-t PCR on BTM showed that a high number of infected herds 
(50%) is misclassified as uninfected with only a single test performed. These results, 
taking in account that r-t PCR is a very sensitive method (EFSA 2010), demonstrated that 
C. burnetii shedding in milk is one of the possible outcomes of this infection in dairy herds 
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(Guatteo, 2006), but not always and during the whole period, there were cows shedding C. 
burnetii in milk, therefore a single BTM sample could not be able to detect all infected 
herds. Conversely the specificity of the BTM r-t PCR was excellent and all the uninfected 
herds have been correctly classified. Hence the combination of r-t PCR and seroprevalence 
assessment could be a useful tool to detect uninfected herds. 
Another aspect that should be considered in dairy herds is the use of BTM to detect 
antibodies against C. burnetii. In this study all herds with negative abortions were tested 
with ELISA using BTM, before the assessment of the seroprevalence using a randomized 
sample of cows. We observed that among the 22 herds with negative abortions, 12 (55%) 
had a seroprevalence ≥ 20%, thus the ELISA test on BTM was not able to detect many 
herds with a seroprevalence that is consistent with the presence of C. burnetii infection in 
the herd (Sidi-Boumedine et al, 2010; Guatteo et. al., 2011). 
The prevalence of C. burnetii infection in dairy goat flocks in North-eastern Italy was 
unknown at the beginning of this study. The results of tests performed on sampled flocks 
highlighted that the 30% of flocks were infected, according to the definition of infected 
flock used in this study. Of course this data are only an indication of the possible existing 
prevalence, because the object of the study was not to perform an assessment of the 
infection prevalence and the flocks sample was not designed for this purpose.  
The absence of specific clinical symptoms in infected ruminants have been described in 
literature (Arricau-Bouvery and Rodolakis, 2005), but especially in caprine flocks Q fever 
abortions can affect sometime up to 90% of females (Palmer et al., 1983). In this study we 
observed only the occurrence of sporadic abortions in infected flocks and in many cases 
the detection of C. burnetii was performed from vaginal swabs of goats that had delivered 
normal and vital kids.  
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Among the flocks with a C. burnetii positive vaginal swab, only 60% showed also a 
seroprevalence ≥ 15%, a very different outcome from the one observed in dairy cattle. It is 
quite difficult to explain this result, because in flocks affected by circulation of C. burnetii 
at the time of kidding, we would expected a high seroprevalence in goats and the absence 
of severe clinical symptoms like "storming abortions" usually means that the disease was 
enzootic in the flock and not a new infection (Berri et al, 2001; Berri et al, 2007). 
We hypothesized that the C. burnetii strains circulating in the flocks were low pathogenic 
so they infected only few goats after shedding at parturition, but further studies are needed 
to confirm this hypothesis. 
All flocks with negative BTM at r-t PCR had also a seroprevalence < 15%. The CFT test 
showed a lower sensitivity in goats compared to cattle. Out of 9 infected flocks with a 
seroprevalence ≥ 15 using ELISA test, only in 2 of them CFT positive goats were found. 
The use of ELISA test with a cut-off that did not include the weak positive samples, 
affected remarkably the classification of infected flocks. The number of infected flocks 
decreased from 9 to 7, thus the use of this cut-off in not advisable in goats. 
The sensitivity of r-t PCR on BTM was equal to 0.8, much better than in cattle and the 
specificity was excellent. The different sensitivity of BTM PCR between cattle and goats is 
probably due to the different pattern of the reproduction cycle in the two species. In goats 
kidding are seasonal, concentrated in few months, the shedding of C. burnetii in milk 
occurred mainly after parturition and milk samples have been collected during this time. In 
dairy cattle calving are widespread throughout the year therefore, in absence of persistent 
shedders, until the calving of a new infected cow, a single BTM sample can produce a 
negative result even in an infected herd.  
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2.3.2 Evaluation of the dynamics of the antibodies response and the C. burnetii 
excretion in infected animals 
The results of the tests performed in dairy herds highlighted a remarkable difference 
between the amount of cows shedding C. burnetii and the seropositive ones. 
As showed in table 13 and 14 the seroprevalence evaluated by means of ELISA testing was 
very high, while the shedding of C. burnetii occurred in up to a maximum of 13% of cows. 
This result, in agreement with the outcome of other studies (Guatteo et al., 2007; Sidi-
Boumedine et al., 2010), highlighted that cows remained seropositives for long time after 
the infection, when the shedding of C. burnetii had stopped several months before. 
The number of cows shedding C. burnetii in milk was lower than the one reported in other 
studies (Guatteo et al., 2007; Guatteo et al., 2011), where the percentage of shedding cows 
was close to 40%. Among these shedding cows it is interesting to observe that the 
percentage of high shedders was very low (0-4%). One possible explanation could be the 
time elapsed between the abortion of positive cows and the first sample of milk or that the 
disease was enzootic in all herds sampled during the study, so that a balance between cows 
and etiological agent might have established. As reported in another study (Guatteo et al., 
2007), we observed that all these high shedding cows excreted the bacterium in milk 
throughout the time they remained in the herd, thus they seemed to have an important role 
in maintaining the infection in the herd (Guatteo et al., 2007). Therefore detection and 
culling of these cows would be advisable, but of course to perform repeated r-t PCR tests 
on individual milk samples of all cows is a very expensive strategy. Hence we observed 
that all the high shedding cows were also high positive ELISA reactors, therefore a 
strategy based on a two step screening, first ELISA and then r-t PCR on the milk of high 
ELISA positive cows, could be useful to detect the high persistent shedders of the herd. 
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The occurrence of seronegative cows shedding C. burnetii in milk has been reported in 
some study (Rodolakis, 2006; Guatteo et al., 2007; Guatteo et al., 2012) and this event has 
been explained as a transitory phase that occurs at the beginning of the infection, or as a 
lack of sensitivity to the serological test (Rodolakis 2006). In this study 14 seronegative 
cows shedding C. burnetii in milk were found. Out of these cows, 13 were present till the 
end of the study and only 1 cow showed a transitory seroconversion at 3rd sampling. In this 
case both hypothesis used to explain this outcome of C. burnetii infection are unsuitable 
because we are not at the beginning of the infection and the ELISA test detected correctly 
the antibodies in all the other cows shedding C. burnetii in milk. A possible explanation of 
this event could be the presence in these cows of a strong cell-mediated immune response 
with low or absent production of antibodies, due to the efficacy of the cell-mediated 
response. 
The excretion of C. burnetii in these cows lasted for a very short time: at 2nd sampling 12 
cows were negative at r-t PCR test on milk and from the 3rd sampling all cows in the group 
were negative. For this reason these cows might not seem very relevant for the 
epidemiology of the infection.  
The group of ELISA- PCR- cows provided a figure of the widespread patterns of the 
infection among lactating cows. In this group 2 cows tested positive at the r-t PCR in milk 
respectively at 3rd and 4th sampling but they didn't seroconvert; at the same time 7 cows had 
a transitory seroconversion only at 2nd sampling. The hypothesis of a strong cell-mediated 
immune response with low or absent production of antibodies could also be used to explain 
this event. This hypothesis is supported by the findings of a study performed in Germany 
(Schumacher et al., 2011) using the γ Interferon production test, that showed the presence 
of seronegative cows with strong cell-mediated immune response against C. burnetii. Thus 
we can hypothesized that some cows after infection with C. burnetii develop mainly a 
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strong cell-mediated response that avoid the persistence of the bacterium in the cow and 
therefore the production of antibodies in these animals is very low and transient.  
In the group of ELISA+PCR- cows we observed that almost 40% of them had at least 1 
positive milk sample with r-t PCR. This result matches the findings reported in other 
studies (Guatteo et. al 2007; Rodolakis, 2006) on the occurrence of discontinuous excretion 
in milk, where a single PCR test was not enough to detect all shedding cows. The opposite 
happened in the ELISA+PCR+ group : these cows became negative at the PCR in milk 
over the time and at the end of the study, only 6 cows were still positive. In all cows of this 
group serology was positive throughout the study. 
The excretion of C. burnetii in feces was merely occasional: only 9 cows were found 
positive and many of them were ELISA-PCR-. This result matched the findings of Guatteo 
et al. (2007) and highlighted the poor relevance of cows in the widespread of the bacterium 
in the environment, compared to other ruminants, especially sheep, that can shed large 
amounts of C. burnetii in the feces (Rodolakis et al., 2006). 
The detection of cows excreting C. burnetii is an important but difficult task in the 
diagnosis of the infection in dairy herds, due to the different ways of shedding and to 
discontinuous excretion of the bacterium. The use of repeated molecular analysis on 
different biological substrate could achieve this result, but this approach is economically 
unsustainable. The use of serological test only is, on the other hand, unreliable because the 
presence of antibodies lasts for a long time after the infection (Sidi-Boumedine et. al., 
2010). 
In this study we evaluated the association between the serological response of the cow to 
ELISA or CFT tests and the occurrence of C. burnetii shedding in milk. We select the milk 
as substrate to evaluate the shedding, because a previous study demonstrated that it is the 
only biological excretion with a fair level of agreement between PCR and serology (Natale 
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et al., 2012). This better level of agreement is probably due to the long lasting shedding of 
C. burnetii in milk and not in other biological excretions (EFSA, 2010; Guatteo et al., 
2007). The level of statistical association was evaluated by estimation of the OR, a 
parameter that measures the different probability of a serological positive cow to be 
shedders of C. burnetii in milk compared to a serological negative cow. The results 
obtained highlighted a high statistically significant association, especially for the detection 
of persistent shedders of both ELISA and CFT, with values of OR equal to 6.8 for CFT and 
29.4 for ELISA. The great majority of persistent shedding cows were positive at the 
ELISA test, 22 out of 24 and this explains the very high value of the OR, but the number of 
cows that tested positive to ELISA was too high (181) to adopt this test as a prescreening 
to select cows for r-t PCR on milk. On the other side the OR of the CFT was too low to use 
this test for prescreening, due to the high number of persistent shedder (14) that were 
negative to CFT.  
Cows with a high serological titer (s/p>2) to ELISA have a greater probability of being 
persistent shedders (Guatteo et al. (2007), for this reason we checked whether using this 
cut-off value would reduce the number of positive cows, while keeping a good chance to 
detect the ones shedding C. burnetii in milk. Using this criteria to detect seropositive cows, 
a high statistical association (OR 8.4) was found between serological results and r-t PCR in 
milk and out of 24 persistent shedding cows only 7 had an ELISA s/p value ≤ 2. Moreover 
the number of seropositive cows using this cut-off were 85, a number that might enable the 
use of the test as a prescreening to select the cows to test with r-t PCR in milk. 
The evaluation of the C. burnetii excretion patterns in 3 goat flocks has provided several 
interesting data that can be compared with those observed in the dairy herds. 
The results of the study on flocks highlighted the great variability in the features of C. 
burnetii excretion in goats, also if we must take into account the difference of the size 
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among the flocks. The shedding of C. burnetii in milk at 1stfirst sampling involved all the 
goats in flock 2, 60% of the goats in flock 1 and only 1% in flock 3. The percentage of 
seropositive goats with ELISA test was high and quite similar among flocks, therefore the 
disease had probably already been present in the farm since at least the previous 
reproductive season. The great variability in the number of goats shedding in milk could be 
due to different management procedures and this could explain the low percentage of 
shedders in flock 3, which had better quality housing, facilities and health management. 
These management features can contribute to reduce the widespread of the infection within 
the herd and thus reduce also the number of infected goats. 
After 2 months from the first sample, the excretion of C. burnetii in milk decreased 
dramatically also in flock 1 and 2, highlighting a big difference with the dairy herds. In 
cows the number of shedders in milk took longer to decline and at the end of the study 
there were some cows still positive to r-t PCR in milk.  
Also in fecal excretion of C. burnetii there were some differences among the 3 flocks: in 
flock 2 and 3 the detection of positive goats was sporadic while in flock 1 the number of 
fecal shedder was greater and relatively long-lasting. This difference among flocks seems 
to be more connected with individual factors, like the type of strain and the response of the 
animal, than to management and housing systems. 
Among the goats shedding C. burnetii in feces, there were some seropositive animals but 
showing PCR-negative milk and also some seronegative ones, thus this excretion manner 
might be in goats the only way of C. burnetii shedding, as it happens in sheep (EFSA, 
2010). 
It should be emphasized that all the ct were > 31, therefore the bacterial load per gram of 
feces was low, aspect of great importance because small ruminant feces for their physical 
features could be very dangerous for the spill-over of the infection from animals to 
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humans, as demonstrated in several of the outbreaks occurred in the last decades (Arricau-
Bouvery et al., 2001; Berri et al., 2004; EFSA, 2010; Manfredi_Selvaggi, 1986; Starnini et 
al., 2005). 
The serological response to the ELISA test highlighted a high percentage of positive 
animals, enforcing the evidence already obtained in the study on BTM r-t PCR 
performance, that infected flocks have a seroprevalence as high as the one of dairy herds. 
Therefore for diagnostic purpose is always useful to evaluate the seroprevalence of goats 
flocks when Q fever infection is suspected.  
The serological response to CFT was very peculiar: at 1st sampling the percentage of 
positive goats was low or even 0, in the following samplings there were many positive 
results, but only for one single sampling and then the goats returned negatives.  
These results confirmed in part the lack of sensitivity of CFT compared to ELISA (OIE, 
2015), but moreover they highlighted the low reliability of CFT in goats, due to this great 
variability in the serological response. Further studies are needed to clarify whether this 
test response is associated with specific immunological features of humoral response or it 
depends on the kind of C. burnetii strains involved in the herd infection.  
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2.4 CONCLUSIONS 
 
This study focused on the evaluation of diagnostic methods used for the detection of the C. 
burnetii infection in cattle and goats. The diagnosis of the infection should involve the use 
of multiple techniques and can be validly interpreted only at herd or flock level. For this 
purpose both serological and molecular assays were evaluated, the dynamics of the 
antibodies response were studied  and the ways of C. burnetii excretion in cows and goats.  
The assessment of diagnostic methods lead to the conclusion that detection of infected 
herds or flocks needs the simultaneous use of assays able to detect the bacterium and the 
presence of antibodies, since the assessment of the seroprevalence has proved very helpful 
to recognize the presence of active infections in farms, especially in goats flocks.  
The use of r-t PCR on BTM alone was assessed in the study because it could be a useful 
and cheap tool for detection of infected herds or flocks. However the research outcome 
suggested that the results of this assay should be carefully evaluated to avoid 
misinterpretations. In dairy herds a single r-t PCR test on BTM is reliable only in case of 
positive result, while in case of negative result, the test has a 50%failure probability. In this 
situation it is advisable to check the within herd seroprevalence and to repeat the test after 
1-2 months. In goats flocks, if the BTM is collected just at the end of the kidding season, 
when the probability of having C. burnetii shedding in milk is highest, the test’s sensitivity 
reaches the value of 80%, therefore negative results are more reliable. In this case, to 
increase sensitivity, it is enough to check the seroprevalence of the flock without repeating 
the BTM sample that, after 2 months, could be negative because the excretion of C. 
burnetii in milk has stopped. 
The detection of persistent shedders in dairy herds could be an important tool to reduce the 
risks of transmission among animals. Serological tests could provide useful information on 
100 
 
the cow’s status and thus they can be used as a screening tool of the herd before testing 
with r-t PCR the milk, with the aim to reduce the cost of analysis. The results obtained in 
this study highlighted the possibility to use the ELISA test to screen the herd and then 
analyze with r-t PCR only the milk of high positive cows. This allowed to detect the great 
majority of the persistent shedders present in the herds. 
The excretion of C. burnetii in dairy cows after the time of calving occurred mainly in milk 
and the bacterium was found in feces only sporadically. During the study some cows 
showed persistent shedding in milk throughout the 6 months of observation and others 
shed C. burnetii discontinuously or only occasionally. In this study we also found some 
seronegative cows shedding C. burnetii in milk that did not show any seroconversion until 
the end of the trial. The occurrence of seronegative cows shedding C. burnetii in milk has 
been reported in some studies (Rodolakis, 2006; Guatteo et al., 2007; Guatteo et al., 2012) 
and this event has been explained as a transitory phase that occurs at the beginning of the 
infection or as a lack of sensitivity of the serological test (Rodolakis 2006). The results of 
this study suggest a different explanation for this event because we followed the cows for 6 
months and the test was performing correctly with all the other cows shedding C. burnetii 
in milk. We hypothesized that some cows after infection with C. burnetii develop mainly a 
strong cell-mediated response that avoid the persistence of the bacterium in the cow and 
therefore the production of antibodies in these animal is very low and transient. Further 
investigation are needed to increase the knowledge of the immune response in ruminants, 
because they could provide important explanations about the behavior of the bacterium in 
these animals. 
C. burnetii excretion in caprine flocks was more diversified than in cattle, especially the 
shedding of the bacterium in feces occurred with a higher probability, while the excretion 
in milk lasted on average only 1 month, even if few long-lasting shedders were found in 1 
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goat flock as well. 
The serological response to the ELISA assay was high in all flocks tested, enforcing the 
evidence that infected flocks have a seroprevalence high as the one of the dairy herds. 
Oppositely CFT test showed a poor sensitivity compared to ELISA and we observed great 
a variability in the serological response of goats to CFT, therefore the test results had poor 
reliability. 
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2.5 TABLES, FIGURES AND GRAPHS 
 
Table 1: amplification program used for carry out the r-t PCR execution 
R-T PCR PROGRAM FOR COXIELLA BURNETII 
 Slope   Acquis i t ion 
Step 1: HOT START 20 
50°C / 2 min.  
and after  
95°C / 10 min. 
None  
Step 2: DENATURATION 1,5 95°C / 15 sec None  
Step 3: ANNEALING/ 1,5 60°C / 1 min Single  
CYCLES N°from Step 2 to Step 3  45 / /  
COOLING 20 40°C / infinite None  
 
 
Table 2: Results of ELISA serological test on blood samples for the within-herd 
seroprevalence assessment and BTM r-t PCR test, performed in dairy cattle herds, sorted 
by presence (herds with C. burnetii abortion) or absence (herds without C. burnetii 
abortion) of abortions with a positive r-t PCR for C. burnetii. Sera were defined positive 
when ELISA s/p value was > 0.4.  
 
 
  
herds with C. burnetii 
abortions
% herds without C. burnetii 
abortions
%
Herds number 17 - 22 -
Herds with seroprevalence < 20% 1 6% 10 45%
Herds with seroprevalence ≥ 20% 16 94% 12 55%
Herds with BTM PCR + 9 53% 6 27%
Herds with seroprevalence ≥ 20% BTM PCR + 8 47% 6 27%
Herds with seroprevalence < 20% BTM PCR - 8 47% 6 27%
Herds with seroprevalence < 20% BTM PCR + 1 6% 0 0%
Herds with seroprevalence < 20% BTM PCR - 0 0% 10 45%
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Table 3: Results of CFT serological test on blood samples for the within-herd 
seroprevalence assessment and BTM r-t PCR test, performed in dairy cattle herds, sorted 
by presence (herds with C. burnetii abortion) or absence (herds without C. burnetii 
abortion) of abortions with a positive r-t PCR for C. burnetii.  
 
 
Table 4: Contingency table showing the ability of a single r-t PCR test performed on BTM 
to detect C. burnetii infection in a herd. The herd status, infected or uninfected has been 
defined according to within-herd seroprevalence and presence/absence of C. burnetii 
abortion. Within-herd seroprevalence was estimated using ELISA test with a s/p value cut-
off > 0.4. 
 
 
 
Table 5: Contingency table showing the ability of a single r-t PCR test performed on BTM 
to detect C. burnetii infection in a herd. The herd status, infected or uninfected has been 
defined according to within-herd seroprevalence and presence/absence of C. burnetii 
abortion. Within-herd seroprevalence was estimated using CFT test. 
 
 
  
herds with C. burnetii 
abortions
% herds without C. burnetii 
abortions
%
Herds number 17 - 22 -
Herds with seroprevalence < 20% 4 24% 17 77%
Herds with seroprevalence ≥ 20% 12 71% 5 23%
Herds with BTM PCR + 9 53% 6 27%
Herds with seroprevalence ≥ 20% BTM PCR + 8 50% 4 18%
Herds with seroprevalence < 20% BTM PCR - 4 25% 1 5%
Herds with seroprevalence < 20% BTM PCR + 1 6% 2 9%
Herds with seroprevalence < 20% BTM PCR - 3 19% 15 68%
Uninfected Infected
Number 10 8 18
% (refered to herds status) 100% 50% 69%
Number 0 8 8
% (refered to herds status) 0% 50% 31%
Number 10 16 26
% (refered to herds status) 100% 100% 100%
Herds status
Total
PCR BTM Negative
Positive
Total
Uninfected Infected
Number 15 4 19
% (refered to herds status) 88% 33% 66%
Number 2 8 10
% (refered to herds status) 12% 67% 34%
Number 17 12 29
% (refered to herds status) 100% 100% 100%
PCR BTM Negative
Positive
Herds status
Total
Total
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Table 6: Results of ELISA serological test on blood samples for the within-herd 
seroprevalence assessment and BTM r-t PCR test, performed in dairy cattle herds, sorted 
by presence (herds with C. burnetii abortion) or absence (herds without C. burnetii 
abortion) of abortions with a positive r-t PCR for C. burnetii. Sera were defined positive 
when ELISA s/p value was > 1.  
 
 
 
Table 7: Contingency table showing the ability of a single r-t PCR test performed on BTM 
to detect C. burnetii infection in a herd. The herd status, infected or uninfected has been 
defined according to within-herd seroprevalence and presence/absence of C. burnetii 
abortion. Within-herd seroprevalence was estimated using ELISA test with a s/p value cut-
off > 1. 
 
 
 
Table 8: Results of ELISA serological test on blood samples for the within-flock 
seroprevalence assessment, and BTM r-t PCR test, performed in dairy goat flocks, sorted 
by presence (flocks with C. burnetii + vaginal swabs) or absence (flocks with C. burnetii - 
vaginal swabs) of C. burnetii in vaginal swabs. Sera were defined positive when ELISA s/p 
value was > 0.4.  
 
 
  
herds with C. burnetii 
abortions
% herds without C. burnetii 
abortions
%
Herds number 17 - 22 -
Herds with seroprevalence < 20% 1 6% 14 64%
Herds with seroprevalence ≥ 20% 16 94% 8 36%
Herds with BTM PCR + 9 53% 6 27%
Herds with seroprevalence ≥ 20% BTM PCR + 8 47% 6 27%
Herds with seroprevalence < 20% BTM PCR - 8 47% 2 9%
Herds with seroprevalence < 20% BTM PCR + 1 6% 0 0%
Herds with seroprevalence < 20% BTM PCR - 0 0% 14 64%
Uninfected Infected
Number 14 8 22
% (refered to herds status) 100% 50% 73%
Number 0 8 8
% (refered to herds status) 0% 50% 27%
Number 14 16 30
% (refered to herds status) 100% 100% 100%
Total
Herds status
Total
PCR BTM Negative
Positive
Flocks with C. burnetii+ 
vaginal swabs
% Flocks with C. burnetii- 
vaginal swabs
%
Flocks number 15 14
Flocks with seroprevalence ≥ 15% 9 60% 0 7%
Flocks with BTM PCR + 8 47% 0 0%
Flocks with seroprevalence ≥ 20% BTM PCR + 7 47% 0 0%
Flocks with seroprevalence < 20% BTM PCR - 2 13% 0 0%
Flocks with seroprevalence < 20% BTM PCR + 1 7% 0 0%
Flocks with seroprevalence < 20% BTM PCR - 5 33% 14 100%
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Table 9: Results of CFT serological test on blood samples for the within-flock 
seroprevalence assessment, and BTM r-t PCR test, performed in dairy goat flocks, sorted 
by presence (flocks with C. burnetii + vaginal swabs) or absence (flocks with C. burnetii - 
vaginal swabs) of C. burnetii in vaginal swabs.  
 
 
 
Table 10: Contingency table showing the ability of a single r-t PCR test performed on 
BTM to detect C. burnetii infection in a flock. The flock status, infected or uninfected has 
been defined according to within-flock seroprevalence and presence/absence of C. burnetii 
in vaginal swabs. Within-flock seroprevalence was estimated using ELISA test with a s/p 
value cut-off > 0.4. 
 
 
 
Table 11: Results of ELISA serological test on blood samples for the within-flock 
seroprevalence assessment and BTM r-t PCR test, performed in dairy goat flocks, sorted 
by presence (herds with C. burnetii + vaginal swabs) or absence (herds with C. burnetii - 
vaginal swabs) of C. burnetii in vaginal swabs. Sera were defined positive when ELISA s/p 
value was > 1.  
 
 
 
  
Flocks with C. burnetii+ 
vaginal swabs
% Flocks with C. burnetii- 
vaginal swabs
%
Flocks number 15 14
Flocks with seroprevalence ≥ 15% 9 60% 1 7%
Flocks with BTM PCR + 8 47% 0 0%
Flocks with seroprevalence ≥ 20% BTM PCR + 7 47% 0 0%
Flocks with seroprevalence < 20% BTM PCR - 2 13% 1 7%
Flocks with seroprevalence < 20% BTM PCR + 1 7% 0 0%
Flocks with seroprevalence < 20% BTM PCR - 5 33% 13 93%
Uninfected Infected
Number 14 2 16
% (refered to flocks status) 100% 22% 70%
Number 0 7 7
% (refered to flocks status) 0% 78% 30%
Number 14 9 23
% (refered to flocks status) 100% 100% 100%
Flocks status
Total
PCR BTM Negative
Positive
Total
Flocks with C. burnetii+ 
vaginal swabs
% Flocks with C. burnetii- 
vaginal swabs
%
Flocks number 15 14
Flocks with seroprevalence ≥ 15% 7 47% 0 0%
Flocks with BTM PCR + 8 53% 0 0%
Flocks with seroprevalence ≥ 20% BTM PCR + 7 47% 0 0%
Flocks with seroprevalence < 20% BTM PCR - 0 0% 0 0%
Flocks with seroprevalence < 20% BTM PCR + 1 7% 0 0%
Flocks with seroprevalence < 20% BTM PCR - 7 47% 14 100%
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Table 12: Contingency table showing the ability of a single r-t PCR test performed on 
BTM to detect C. burnetii infection in a flock. The flock status, infected or uninfected has 
been defined according to within-flock seroprevalence and presence/absence of C. burnetii 
in vaginal swabs. Within-flock seroprevalence was estimated using ELISA test with a s/p 
value cut-off > 1. 
 
 
 
Table 13: Results of serological test (ELISA and CFT) for C. burnetii antibodies 
detection, performed on the blood sample of each lactating cow at first sampling, in the 4 
dairy herds enrolled in the trial for the evaluation of the dynamics of the antibodies 
response and the C. burnetii excretion in infected animals. For ELISA test a double cut-
off has been used: s/p value > 0.4, to include all the positive samples and s/p value > 2 to 
include only the high and very high positive samples. 
 
 
 
Table 14: Results of the r-t PCR test for C. burnetii DNA detection performed on the 
milk of each lactating cow at first sampling in the 4 dairy herds enrolled in the trial for 
the evaluation of the dynamics of the antibodies response, and the C. burnetii excretion in 
infected animals. The last 2 columns highlight the number and percentage of high 
shedders of C. burnetii in milk (ct value ≤ 31). 
 
 
  
Uninfected Infected
Number 14 0 14
% (refered to flocks status) 100% 0% 67%
Number 0 7 7
% (refered to flocks status) 0% 100% 33%
Number 14 7 21
% (refered to flocks status) 100% 100% 100%
Total
Flocks status
Total
PCR BTM Negative
Positive
Herd N° cows 
tested 
CFT 
 
 
CFT  
(%) 
ELISA  
s/p >0.4 
ELISA 
s/p >0.4 
(%) 
ELISA 
s/p >2 
ELISA 
s/p >2 
(%) 
Herd 1 107 17 15.9% 42 39.3% 17 15.9% 
Herd 2 107 12 11.2% 23 21.5% 4 3.7% 
Herd 3 100 8 8.0% 48 48.0% 34 34.0% 
Herd 4 294 28 9.5% 68 23.1% 30 10.2% 
Total 608 65 10.7% 181 29.8% 85 14.0% 
 
Herd N° cows 
tested 
PCR + PCR + 
(%) 
PCR + 
Ct≤31 
PCR +  
Ct≤31 (%) 
Herd 1 107 11 10.3% 4 3.7% 
Herd 2 107 14 13.1% 0 0.0% 
Herd 3 100 10 10.0% 4 4.0% 
Herd 4 294 13 4.4% 4 1.4% 
Total 608 48 7.9% 12 2.0% 
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Table 15: Size of the 4 groups of cows established according to the results of ELISA and 
r-t PCR in milk, at each time of sampling.  
 
 
 
Table 16: Variation along the time of the serological and shedding status of the cows 
during the study at each sampling: changes of status at each sampling (T2-T3-T4) are 
highlighted by the gray fill of the cells and the character in bold. The last 2 columns list the 
cows dried-off or culled at each sampling. 
 
 
 
  
Group T1 T2 T3 T4 Totale 
ELISA -_PCR- 49 48 41 39 177 
ELISA -_PCR+ 14 14 13 13 54 
ELISA +_PCR- 43 43 40 38 164 
ELISA +_PCR+ 34 29 21 19 103 
Totale complessivo 140 134 115 109 498 
 
GROUP 1 SAMPLING TIME ELISA -_PCR- ELISA -_PCR+ ELISA +_PCR- ELISA +_PCR+ DRY-OFF CULLED
ELISA -_PCR- T1 49 0 0 0 0 -
T2 40 1 7 0 0 1
T3 34 1 0 0 6 7
T4 37 1 0 0 1 2
GROUP 2 SAMPLING TIME ELISA -_PCR+ ELISA -_PCR- ELISA +_PCR- ELISA +_PCR+ DRY-OFF CULLED
ELISA -_PCR+ T1 14 0 0 0 0 -
T2 2 8 0 0 4 0
T3 0 12 1 0 0 1
T4 0 11 0 0 2 0
GROUP 3 SAMPLING TIME ELISA +_PCR- ELISA -_PCR- ELISA -_PCR+ ELISA +_PCR+ DRY-OFF CULLED
ELISA +_PCR- T1 43 0 0 0 0 -
T2 26 0 0 14 3 0
T3 24 2 0 7 7 3
T4 26 2 0 5 5 2
GROUP 4 SAMPLING TIME ELISA +_PCR+ ELISA -_PCR- ELISA -_PCR+ ELISA +_PCR- DRY-OFF CULLED
ELISA +_PCR+ T1 34 0 0 0 0 -
T2 17 0 0 9 3 5
T3 8 0 0 4 9 8
T4 6 0 0 13 2
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Table 17: List of the cows with positive PCR test for the detection of C. burnetii DNA in 
feces. The table shows for each cow: the herd, the number of samplings that tested 
positive, the results of ELISA test (expressed as s/p ratio) and PCR in milk at the same 
sampling and the cow group with reference to the test results of the first sampling. 
 
 
*The results are reported as s/p value ratio, positive cows have a s/p > 0.4 
**d= dried-off cows, 0 = negative result to the PCR 
 
Table 18: Contingency table showing the comparison between the shedding of C. burnetii 
in milk measured by r-t PCR and the serological status of the cows, measured with ELISA 
and CFT test. Data are expressed in absolute value and in percentage. 
 
 
 
Table 19: Contingency table showing the comparison between the shedding of C. burnetii 
in milk measured by r-t PCR and the serological status of the cows, measured with ELISA 
with 2 different cut-off: s/p > 0.4 and s/p > 2 (only high positive cows). Data are expressed 
in absolute value and in percentage. 
 
 
  
Herd Sampling 
Number 
Animal 
ID 
*ELISA 
test result  
**Milk PCR 
result 
Feces PCR 
result (Ct) 
Group 
2 2 490 0.05 0 29.3 ELISA -_PCR- 
1 4 467 0.00 0 37.15 ELISA -_PCR- 
1 2 603 0 0 37.2 ELISA -_PCR- 
1 4 660 0.04 d 38.23 ELISA -_PCR- 
1 3 672 0 0 38.27 ELISA -_PCR- 
1 2 570 0 0 37.12 ELISA -_PCR+ 
1 4 666 2.62 d 38.86 ELISA +_PCR- 
1 2 638 1.94 0 38.05 ELISA +_PCR+ 
1 3 650 4.41 d 37.14 ELISA +_PCR+ 
 
 CFT  ELISA s/p > 0,4 
PCR - + Total PCR - + Total 
- 512 48 560 - 413 147 560 
+ 31 17 48 + 14 34 48 
Total 543 65 608 Total 427 181 608 
% - +  % - +  
- 91.4% 8.6% ----- - 73.8% 26.3% ----- 
+ 64.6% 35.4% ----- + 29.2% 70.8% ----- 
 
 ELISA s/p > 2  ELISA s/p > 0,4 
PCR - + Total PCR - + Total 
- 501 59 560 - 413 147 560 
+ 22 26 48 + 14 34 48 
Total 523 85 608 Total 427 181 608 
% - +  % - +  
- 89.5% 10.5% ----- - 73.8% 26.3% ----- 
+ 45.8% 54.2% ----- + 29.2% 70.8% ----- 
 
109 
 
Table 20: assessment of the statistical association between the serological status of the 
cows in infected herds and the occurrence of C. burnetii shedding in milk, comparing the 
results of ELISA with 2 different cut-off (s/p > 0.4 and s/p > 2) and of CFT. The 
association is evaluated including all the shedders cows and considering only the persistent 
shedder cows. The level of association was evaluated by mean of the Odd ratio (95% 
Confidence interval CI is reported). All the association tested had a p value = 0.00. 
 
 
 
Table 21: Contingency table showing the comparison between the persistent shedding of 
C. burnetii in milk (cows with at least 2 positive milk PCR test) and the serological status 
of the cows at first sampling, measured with ELISA with 2 different cut-off: s/p > 0.4 and 
s/p > 2 (only high positive cows). Data are expressed in absolute value and in percentage. 
 
 
 
Tabella 22: results of serological (ELISA and CFT) and molecular (r-t PCR) tests 
performed on blood, milk and feces of each lactating goat at 1st sampling in the 3 dairy 
flocks enrolled in the trial for the evaluation of the dynamics of the antibodies response 
and the C. burnetii excretion in infected animals. 
 
 
  
 All cows shedding C. burnetii in milk Persistent shedder cows 
Test OR CI 95% OR CI 95% 
CFT 5.8 3.01 - 11.33 6.8 2.91 - 16.20 
ELISA S/p >0,4 6.8 3.56 – 13.07 29.4 6.83 - 126.47 
ELISA S/p >2 10.03 5.35 - 18.81 18.4 7.37 - 46.04 
 
 ELISA s/p > 2  ELISA s/p > 0,4 
PCR - + Total PCR - + Total 
- 516 68 584 - 425 159 584 
+ 7 17 24 + 2 22 24 
Total 523 85 608 Total 427 181 608 
% - +  % - +  
- 88.4% 11.6% ----- - 72.8% 27.2% ----- 
+ 29.2% 70.8% ----- + 8.3% 91.7% ----- 
 
  Flock 1 Flock 2 Flock 3 
 Time of sampling T1 T2 T3 T4 T1 T2 T3 T4 T1 T2 T3 T4 
Goats sampled 74 20 19 19 12 12 12 11 171 23 21 21 
ELISA + 56 17 16 15 10 9 10 9 111 12 13 13 
CFT + 0 7 2 0 0 3 0 0 11 0 19 5 
 PCR + milk 45 1 0 2 12 1 0 0 2 2 2 1 
 PCR + feces - 15 13 5 0 1 1 0 0 1 0 0 
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Table 23: results of serological (ELISA and CFT) and molecular (r-t PCR) tests performed 
on blood, milk and feces of each lactating goat at each of the 4 sampling in the 3 dairy 
flocks. Data are expressed as percentage of goats positive to each test with reference to the 
total number of goat sampled at each sampling. 
 
 
 
Graph 1:Summary of the results of ELISA and r-t PCR test performed at 1st sampling 
sorted by flock: the bars highlight the total number of goats sampled (gray bars), the 
number of ELISA test positive goats(black bars) and the number of r-t PCR goats positive 
on milk (white bars). 
 
 
  
  Flock 1 Flock 2 Flock 3 
 Time of sampling T1 T2 T3 T4 T1 T2 T3 T4 T1 T2 T3 T4 
ELISA + 76% 85% 84% 79% 83% 75% 83% 82% 65% 52% 62% 62% 
CFT + 0% 35% 11% 0% 0% 25% 0% 0% 6% 0% 90% 24% 
 PCR + milk 61% 5% 0% 11% 100% 8% 0% 0% 1% 9% 10% 5% 
 PCR + feces - 75% 68% 26% 0% 8% 8% 0% 0% 4% 0% 0% 
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